DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	DSCAM; SHOX2; GDF11; SEMA4F; INHBA; FGF5; MDK; L1CAM; GDNF; LHX1; APLP1; SPOCK1; CRMP1; EFNB3; TTLL7; DPF1; SCN2A; FEZ1; PCDHAC1; PCDHB2; PCDHB12; PCDHA11; PCDHAC2; ROBO1; NTRK1; NTRK2; AXL; NAV1; RBFOX2;	GO:0007399~nervous system development	29	294	9.86394557823129	0	0	0	0	0	0	0
down	TGFB1I1; SLIT3; GDF11; NTRK1; APP; TFAP2A; SERPINE2; INHBA; PTHLH; LIF; FOSL1; IGFBP6; NOTCH1; CDH13; TGFB2; SOX4; IL24; DHRS2; PKD2; PTPRK; PTPN14; PDPN; P3H3; SFRP1; PTPRU; PROX1; E2F7; DLC1; BTG4; ADAMTS1; FBXO2; SCIN;	GO:0008285~negative regulation of cell population proliferation	32	396	8.08080808080808	0	0	0	0	0	0	0
down	TLL1; INHBA; MDK; PGF; FOXL2; HSPG2; BNC1; TTLL7; ARHGAP22; ARHGEF28; OSR1; MYCBPAP; TWIST2; PTPRU; CFAP54; MMP19; RBM24; CADM1; DLX1; DLX2; NR2F2; FOXA2; ETV5; FSTL3; ETV4; CAV1; SOX4; FOXC2; NKX3-2; FOXD1; FOXD2; POU2F2; FSTL1; FOXE1; ONECUT2;	GO:0030154~cell differentiation	35	572	6.11888111888112	0	0	0	0	0	0	0
down	HMGB3; INHBA; SFRP1;	GO:0045578~negative regulation of B cell differentiation	3	5	60	0.00010071414882917	0.00194714021069734	0.260446788872241	0.274546769708325	0.188234744161724	0.260446788872241	0.0165273060233998
down	WTIP; AGRN; SIPA1L3; MDK; FGD1; FGD6; MICAL3; MARK1; AJUBA;	GO:0007010~cytoskeleton organization	9	139	6.47482014388489	0.00010278186069168	0.00197312219891213	0.265691109887995	0.280183352245522	0.190653670689647	0.265691109887995	0.0167478408713594
down	WNT7A; TBX3; HOXC11; SHH; TWIST1; OSR1;	GO:0042733~embryonic digit morphogenesis	6	55	10.9090909090909	0.0001092415484718	0.00208246476317582	0.282280161251146	0.297792461134142	0.197964894247765	0.282280161251146	0.0176759394289472
down	SNAI2; APP; MDK; NOTCH1; CNTN1; DNER; FOXC2; SUSD5;	GO:0007219~Notch signaling pathway	8	109	7.3394495412844	0.00011009425434827	0.00208414539828738	0.284373458981581	0.300116937353383	0.198871561460956	0.284373458981581	0.0176902046424381
down	BMPR1B; SHOX2; COL11A1; RUNX2;	GO:0002063~chondrocyte development	4	17	23.5294117647059	0.00011745138017016	0.0021929620708484	0.303259463599363	0.320172462343866	0.206596977719318	0.303142012219193	0.0186138394366782
down	SNAI2; NOTCH1; CAV1; NTRK2;	GO:2000811~negative regulation of anoikis	4	17	23.5294117647059	0.00011745138017016	0.0021929620708484	0.303259463599363	0.320172462343866	0.206596977719318	0.303142012219193	0.0186138394366782
up	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6; UGT1A10;	GO:0052696~flavonoid glucuronidation	7	7	100	0.00011752891501837	0.0596263362193209	0.535696794653741	0.536637025973888	0.534639034418575	0.535696794653741	0.536858716276437
down	TBX1; TNC; DLX1; DLX2; RUNX2; SHH;	GO:0042475~odontogenesis of dentin-containing tooth	6	57	10.5263157894737	0.00013091414055921	0.00240142291679696	0.337758482642769	0.356871947164414	0.220721240982833	0.337758482642769	0.0203832529467894
down	SH3PXD2B; BMPR1B; SIPA1L3; TGFB2; MAB21L1;	GO:0001654~eye development	5	35	14.2857142857143	0.00013125899288435	0.00240142291679696	0.338516942648747	0.357812014602747	0.221040144017251	0.338385683655863	0.0203832529467894
down	TERT; SNAI2; COL2A1; CSF2; GDNF;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	5	35	14.2857142857143	0.00013125899288435	0.00240142291679696	0.338516942648747	0.357812014602747	0.221040144017251	0.338385683655863	0.0203832529467894
down	LCAT; CAV1; PCSK9; DISP3; LIMA1; LIPG; CYP7B1;	GO:0042632~cholesterol homeostasis	7	83	8.43373493975904	0.00013221985559486	0.00240287550901062	0.340730567867959	0.360431326351593	0.222099600512264	0.340730567867959	0.0203955825345153
down	NOTCH1; ISL1; TGFB2; TWIST1;	GO:0003203~endocardial cushion morphogenesis	4	18	22.2222222222222	0.00014214870232787	0.00248216720363364	0.366032908494268	0.387497362545777	0.232270979603741	0.365464313684957	0.0210686096205715
down	FSTL3; KIF26B; NODAL; MYO10;	GO:0022409~positive regulation of cell-cell adhesion	4	18	22.2222222222222	0.00014214870232787	0.00248216720363364	0.366032908494268	0.387497362545777	0.232270979603741	0.365464313684957	0.0210686096205715
down	BMPR1B; SEMA4F; ISL1; NRCAM;	GO:0031290~retinal ganglion cell axon guidance	4	18	22.2222222222222	0.00014214870232787	0.00248216720363364	0.366032908494268	0.387497362545777	0.232270979603741	0.365464313684957	0.0210686096205715
down	APOD; THBS1; MMP14; DLC1;	GO:0051895~negative regulation of focal adhesion assembly	4	18	22.2222222222222	0.00014214870232787	0.00248216720363364	0.366032908494268	0.387497362545777	0.232270979603741	0.365464313684957	0.0210686096205715
down	TBX1; ISL1; SIX1; SIX4;	GO:0060037~pharyngeal system development	4	18	22.2222222222222	0.00014214870232787	0.00248216720363364	0.366032908494268	0.387497362545777	0.232270979603741	0.365464313684957	0.0210686096205715
down	COL2A1; CD44; PRRX1; EVC; DLX2; SATB2;	GO:0051216~cartilage development	6	58	10.3448275862069	0.00014295680519826	0.00248216720363364	0.367398989359551	0.389700250970481	0.233026537341085	0.367398989359551	0.0210686096205715
down	BMPR1B; GDNF; DLX1; ISL1; DLX2;	GO:0045597~positive regulation of cell differentiation	5	36	13.8888888888889	0.00014797456589188	0.00250323402299765	0.38014665977625	0.403378666621276	0.23794310195415	0.38014665977625	0.0212474245660264
down	SERPINE1; SERPINE2; THBS1;	GO:0010757~negative regulation of plasminogen activation	3	6	50	0.00014967980401636	0.00250323402299765	0.384377736714031	0.408027145748617	0.239529973377958	0.383779017497965	0.0212474245660264
down	NOTCH1; DLX1; DLX2;	GO:0046533~negative regulation of photoreceptor cell differentiation	3	6	50	0.00014967980401636	0.00250323402299765	0.384377736714031	0.408027145748617	0.239529973377958	0.383779017497965	0.0212474245660264
down	CEP290; LHX1; OSR1;	GO:0048793~pronephros development	3	6	50	0.00014967980401636	0.00250323402299765	0.384377736714031	0.408027145748617	0.239529973377958	0.383779017497965	0.0212474245660264
down	SERPINE1; FAM20C; HTRA1;	GO:0097187~dentinogenesis	3	6	50	0.00014967980401636	0.00250323402299765	0.384377736714031	0.408027145748617	0.239529973377958	0.383779017497965	0.0212474245660264
down	ADAMTS3; CCBE1; ROBO1;	GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway	3	6	50	0.00014967980401636	0.00250323402299765	0.384377736714031	0.408027145748617	0.239529973377958	0.383779017497965	0.0212474245660264
down	THBS1; MAP1B; TWIST1; SFRP1; FEZ1; BMPR1B;	GO:0071363~cellular response to growth factor stimulus	6	59	10.1694915254237	0.00015585959941855	0.00259069065862786	0.399468153309746	0.424873268014969	0.244647659491192	0.399468153309746	0.0219897555871293
down	SERPINE1; IL24; PTPRK; SHH; SFRP1; PTPRU; DLC1; ROBO1;	GO:0030336~negative regulation of cell migration	8	116	6.89655172413793	0.00016483119007304	0.00269792100075111	0.422297508967141	0.44932982413912	0.251367564861393	0.422297508967141	0.0228999256249768
down	PDGFA; INHBA; HOXC13; TGFB2; VANGL2;	GO:0001942~hair follicle development	5	37	13.5135135135135	0.00016626952609177	0.00269792100075111	0.425816256321043	0.453250728126187	0.252397140607319	0.42548371726886	0.0228999256249768
down	WNT7A; COL2A1; HMGA2; OSR1; RUNX2;	GO:0002062~chondrocyte differentiation	5	37	13.5135135135135	0.00016626952609177	0.00269792100075111	0.425816256321043	0.453250728126187	0.252397140607319	0.42548371726886	0.0228999256249768
down	GDF11; POU2F2; AXL; RUNX2; LHX6;	GO:0048469~cell maturation	5	37	13.5135135135135	0.00016626952609177	0.00269792100075111	0.425816256321043	0.453250728126187	0.252397140607319	0.42548371726886	0.0228999256249768
down	GJC1; CAV1; SHH; TEAD2; NTRK2; HAS2;	GO:0001570~vasculogenesis	6	60	10	0.00016966595353862	0.00271633463377181	0.434005509151796	0.462509389346285	0.25500792816855	0.434005509151796	0.0230562203521175
down	RUNX2; SHH; SATB2; PTHLH;	GO:0002076~osteoblast development	4	19	21.0526315789474	0.00017039369859683	0.00271633463377181	0.435696687312115	0.46449322237498	0.255526468032775	0.435526293613518	0.0230562203521175
down	ITGA2; POSTN; SEMA6D; HAS2;	GO:0014911~positive regulation of smooth muscle cell migration	4	19	21.0526315789474	0.00017039369859683	0.00271633463377181	0.435696687312115	0.46449322237498	0.255526468032775	0.435526293613518	0.0230562203521175
down	TGFB2; PDPN; CDH13; CDH3; CDH26; CDH11; CDH10;	GO:0000902~cell morphogenesis	7	88	7.95454545454545	0.00018543774254731	0.00291778649352322	0.473793432208382	0.505503286183972	0.266806418562194	0.473793432208382	0.0247661416596859
down	INHBA; KITLG; MMP14; FOXL2; MMP19;	GO:0001541~ovarian follicle development	5	38	13.1578947368421	0.00018624169107595	0.00291778649352322	0.475661279007977	0.50769484987304	0.267412850149824	0.475475037316901	0.0247661416596859
down	AGRN; HSPG2; XYLT2; HS3ST2; GPC6;	GO:0006024~glycosaminoglycan biosynthetic process	5	38	13.1578947368421	0.00018624169107595	0.00291778649352322	0.475661279007977	0.50769484987304	0.267412850149824	0.475475037316901	0.0247661416596859
down	BMPR1B; WNT7A; COL2A1; COL11A1;	GO:0001502~cartilage condensation	4	20	20	0.00020247572928544	0.00313607294336434	0.516718061136456	0.551948838032123	0.279551077338924	0.51651558540717	0.0266189547942848
down	SNAI2; PTHLH; NKX3-2; ADAMTS7;	GO:0032331~negative regulation of chondrocyte differentiation	4	20	20	0.00020247572928544	0.00313607294336434	0.516718061136456	0.551948838032123	0.279551077338924	0.51651558540717	0.0266189547942848
up	S100A8; S100A9; EDN3; LGALS3; EDN2; XCL1; NCKAP1L; CXADR; S100A12; XCL2; CCL8; CCL22; CX3CL1; CCL21; CCL14; CCL17; CCL11; CCL18; CCL19; CXCL13; CCL2;	GO:0030593~neutrophil chemotaxis	21	76	27.6315789473684	0.00020996823509766	0.0958714961455954	0.956825247340075	0.958714961455954	0.854777979736771	0.956825247340075	0.863199914864934
down	FSTL3; INHBA; KITLG; MMP14; TGFB2; SFRP1; SIX4;	GO:0008584~male gonad development	7	90	7.77777777777778	0.00021105194759552	0.0031907765682154	0.538182466368575	0.575327609145387	0.28561589521233	0.538182466368575	0.0270832785977457
down	ANTXR2; ANTXR1; KCNU1;	GO:0022414~reproductive process	3	7	42.8571428571429	0.0002118600729446	0.0031907765682154	0.540031325935793	0.577530558846988	0.286115451318485	0.539395745716959	0.0270832785977457
down	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.0002118600729446	0.0031907765682154	0.540031325935793	0.577530558846988	0.286115451318485	0.539395745716959	0.0270832785977457
down	CYP7B1; TNC; NOTCH1;	GO:0060740~prostate gland epithelium morphogenesis	3	7	42.8571428571429	0.0002118600729446	0.0031907765682154	0.540031325935793	0.577530558846988	0.286115451318485	0.539395745716959	0.0270832785977457
down	LHX1; OSR1; FOXA2;	GO:2000543~positive regulation of gastrulation	3	7	42.8571428571429	0.0002118600729446	0.0031907765682154	0.540031325935793	0.577530558846988	0.286115451318485	0.539395745716959	0.0270832785977457
down	SNAI2; NOTCH1; HMGA2; TGFB2; LOXL2;	GO:0001837~epithelial to mesenchymal transition	5	40	12.5	0.00023162231478313	0.00346924412142206	0.589478791123068	0.631402430098815	0.296285228674109	0.589478791123068	0.0294469083169356
down	NEFL; DLX1; DLX2; CDK5R2; FEZ1; LHX5;	GO:0021766~hippocampus development	6	64	9.375	0.00023483792336354	0.0034981867709782	0.597427677036846	0.64016817908901	0.297940756101884	0.597427677036846	0.029692573227821
down	ITGA3; LOX; SMURF2; DKK3;	GO:0017015~regulation of transforming growth factor beta receptor signaling pathway	4	21	19.047619047619	0.00023868970415552	0.00353623985613024	0.606987917667502	0.650668133527963	0.299801658794808	0.606987917667502	0.030015567422069
down	FN1; FGD1; FGD6; PDPN; BVES; FBLIM1; FERMT2; DLC1; MYO10;	GO:0008360~regulation of cell shape	9	159	5.66037735849057	0.0002666547338308	0.00392919353742043	0.677836333397911	0.726900804422779	0.31385262171886	0.677836333397911	0.0333509542154929
down	FOXE1; TBX1; SHH; SIX1;	GO:0030878~thyroid gland development	4	22	18.1818181818182	0.00027933551899062	0.00409391733746468	0.709791553755165	0.76146862476843	0.32011850476325	0.709791553755165	0.0347491281311215
down	MMP14; SNRPN; STEAP2; MMP19; FOXC2;	GO:0009725~response to hormone	5	42	11.9047619047619	0.00028495176815279	0.00413180063821555	0.723777491108104	0.776778519984524	0.32293746360758	0.723492539339951	0.0350706811971239
down	THBS1; FOSL1; TGFB2; CAV1; DSG2;	GO:0032570~response to progesterone	5	42	11.9047619047619	0.00028495176815279	0.00413180063821555	0.723777491108104	0.776778519984524	0.32293746360758	0.723492539339951	0.0350706811971239
down	MELTF; FSCN1; PDPN;	GO:0090091~positive regulation of extracellular matrix disassembly	3	8	37.5	0.00028862786982664	0.00414105038498644	0.732537533620015	0.786799573147423	0.324757126896836	0.732248905750188	0.0351491929523029
down	SH3PXD2B; FOXE1; TGFB2;	GO:1904888~cranial skeletal system development	3	8	37.5	0.00028862786982664	0.00414105038498644	0.732537533620015	0.786799573147423	0.324757126896836	0.732248905750188	0.0351491929523029
down	PXN; TGFB2; LTBP2; PTPRK; FERMT2; FUT8; TGFB1I1;	GO:0007179~transforming growth factor beta receptor signaling pathway	7	96	7.29166666666667	0.00030544877940785	0.00435944174170586	0.774618104578327	0.83265337266582	0.332633720775157	0.774618104578327	0.0370028965354027
down	TBX1; SHOX2; PDGFA; PRRX1;	GO:0002053~positive regulation of mesenchymal cell proliferation	4	23	17.3913043478261	0.00032471751245388	0.00461031218202758	0.823158894070604	0.885179938949296	0.340953388076581	0.823158894070604	0.0391322822450929
up	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	7	9	77.7777777777778	0.00033102760440395	0.125956003475705	1	1	0.995309242852847	0.999999999716637	1
down	TBX1; RET; TNC; PTK7; TEAD2; OSR1;	GO:0071300~cellular response to retinoic acid	6	69	8.69565217391304	0.00034234611640582	0.00483541716747292	0.867505058972355	0.933235513322273	0.348508346501128	0.867505058972355	0.0410429710395663
down	NOTCH1; VEGFC; TWIST1; SFRP1; TWIST2;	GO:0045668~negative regulation of osteoblast differentiation	5	44	11.3636363636364	0.0003471055033315	0.00485235693375217	0.879218239938694	0.946209602081674	0.350576558364817	0.878871134435363	0.0411867556010088
down	KRT8; INHBA; TGFB2; MLLT11; TNFRSF12A;	GO:0097191~extrinsic apoptotic signaling pathway	5	44	11.3636363636364	0.0003471055033315	0.00485235693375217	0.879218239938694	0.946209602081674	0.350576558364817	0.878871134435363	0.0411867556010088
up	FCN1; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; IGKV3-11; IGKV4-1; IGLC2; IGLC3; IGLV3-21; COLEC10;	GO:0006956~complement activation	23	92	25	0.00036842335515496	0.126985027546459	1	1	0.999999999716638	0.999999999716637	1
down	TBX1; PTK7; SIX1; VANGL2;	GO:0090103~cochlea morphogenesis	4	24	16.6666666666667	0.00037514394291804	0.00512669956816152	0.949489319525568	1	0.362013904915912	0.949489319525568	0.0435153730519961
down	TBX3; CAV1; OSR1;	GO:0030857~negative regulation of epithelial cell differentiation	3	9	33.3333333333333	0.00038129925040131	0.00512669956816152	0.96468710351532	1	0.364452444411122	0.962780607263314	0.0435153730519961
down	ADAMTS3; SERPINH1; P3H3;	GO:0032964~collagen biosynthetic process	3	9	33.3333333333333	0.00038129925040131	0.00512669956816152	0.96468710351532	1	0.364452444411122	0.962780607263314	0.0435153730519961
down	FN1; COL16A1; FERMT2;	GO:0033622~integrin activation	3	9	33.3333333333333	0.00038129925040131	0.00512669956816152	0.96468710351532	1	0.364452444411122	0.962780607263314	0.0435153730519961
down	FBN1; MFAP2; FOXL2;	GO:0048048~embryonic eye morphogenesis	3	9	33.3333333333333	0.00038129925040131	0.00512669956816152	0.96468710351532	1	0.364452444411122	0.962780607263314	0.0435153730519961
down	PXDN; LAMB3; LAMB1;	GO:0070831~basement membrane assembly	3	9	33.3333333333333	0.00038129925040131	0.00512669956816152	0.96468710351532	1	0.364452444411122	0.962780607263314	0.0435153730519961
down	PCSK9; OSR1; HECW1;	GO:2000650~negative regulation of sodium ion transmembrane transporter activity	3	9	33.3333333333333	0.00038129925040131	0.00512669956816152	0.96468710351532	1	0.364452444411122	0.962780607263314	0.0435153730519961
down	DSCAM; LPXN; MDK; TNC; CDH13;	GO:0007162~negative regulation of cell adhesion	5	45	11.1111111111111	0.0003817754997567	0.00512669956816152	0.96468710351532	1	0.364595602267657	0.963601361385934	0.0435153730519961
down	TBX3; TBX1; NOTCH1; ISL1; SIX1;	GO:0003151~outflow tract morphogenesis	5	46	10.8695652173913	0.00041899694619673	0.00554459065695294	1	1	0.378698425859778	0.971764654232744	0.0470624283030579
down	APP; AGRN; LAMC2; EGFLAM; MAP1B;	GO:0016358~dendrite development	5	46	10.8695652173913	0.00041899694619673	0.00554459065695294	1	1	0.378698425859778	0.971764654232744	0.0470624283030579
down	APP; NR2F2; NOTCH1; SHH; DLC1;	GO:0030900~forebrain development	5	46	10.8695652173913	0.00041899694619673	0.00554459065695294	1	1	0.378698425859778	0.971764654232744	0.0470624283030579
down	SERPINB7; VIM; ITGA2; LARP6;	GO:0032967~positive regulation of collagen biosynthetic process	4	25	16	0.00043092648418052	0.0056749062602711	1	1	0.383093644436489	0.971764654232744	0.0481685457998004
up	SRPX2; ANXA9; EGFR; CSTA; ANXA1; JUP; CRISP2; CD24; ICAM3; ITGA8; RAB10; CX3CL1; DSG1; FOXF1; DLG1; TRIM29; COL19A1; TTYH1; CRNN; CTNNA3; BAIAP2; LRRC1; CTNND1; DSG3; CDH12; PKP3; DSC3; DSC2; CDH19; PKP1; DSP; ICOS;	GO:0098609~cell-cell adhesion	32	152	21.0526315789474	0.00044873535582334	0.126985027546459	1	1	0.999999999716638	0.999999999716637	1
down	CDH13; PRKD1; PROX1; CCL26; PGF; VEGFC;	GO:0001938~positive regulation of endothelial cell proliferation	6	73	8.21917808219178	0.00045331914290858	0.00588451420747044	1	1	0.391667739473014	0.971764654232744	0.0499476958934958
down	CYP7B1; LCAT; APP; PCSK9; DISP3; LIMA1;	GO:0008203~cholesterol metabolic process	6	73	8.21917808219178	0.00045331914290858	0.00588451420747044	1	1	0.391667739473014	0.971764654232744	0.0499476958934958
down	NTRK2; RET; EPHB4; IGF1R; AXL; NTRK1;	GO:0033674~positive regulation of kinase activity	6	73	8.21917808219178	0.00045331914290858	0.00588451420747044	1	1	0.391667739473014	0.971764654232744	0.0499476958934958
down	HOXC11; GDNF; SIX1;	GO:0001759~organ induction	3	10	30	0.00049113486152996	0.00628560390859473	1	1	0.405677395623749	0.971764654232744	0.0533521411393474
down	ITGA3; FSTL3; FSTL1;	GO:0030510~regulation of BMP signaling pathway	3	10	30	0.00049113486152996	0.00628560390859473	1	1	0.405677395623749	0.971764654232744	0.0533521411393474
down	MMP14; MMP16; HMGA2;	GO:0035988~chondrocyte proliferation	3	10	30	0.00049113486152996	0.00628560390859473	1	1	0.405677395623749	0.971764654232744	0.0533521411393474
up	TRAV19; NCR3; TYROBP; LILRA1; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; TRBC1; CD3D; IGKV3-11; TRBV7-9; CD1A; IGKV4-1; CD3G; IGLC2; IGLC3; CD8B; CD19; KLRC1; CD1B; CD1C; CD40LG; FCGR2B; ICAM3; CXADR; IGLV3-21; COLEC12; TREML2; CD300LG; LILRB2; LILRB1; RAET1E; CD300LF; CD300A;	GO:0050776~regulation of immune response	41	216	18.9814814814815	0.00051462913737043	0.126985027546459	1	1	0.999999999716638	0.999999999716637	1
down	ONECUT2; NOTCH1; PKD2; PCSK9; PROX1; NODAL;	GO:0001889~liver development	6	75	8	0.00051838803325865	0.00660339148907987	1	1	0.415228814640182	0.971764654232744	0.0560495188444859
up	PLA2G4B; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4F; PLA2G4D; SERAC1; PLA2G12A; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	9	18	50	0.00052929447471772	0.126985027546459	1	1	0.999999999716638	0.999999999716637	1
down	SNAI2; SHOX2; TNC; LOX; RUNX2; TWIST1; SFRP1;	GO:0001649~osteoblast differentiation	7	106	6.60377358490566	0.00053555627237678	0.00679035534185629	1	1	0.420947230088149	0.971764654232744	0.0576364660982962
up	UGT1A9; UGT2B7; UGT1A6; UGT1A1; UGT1A4; UGT1A3; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	8	14	57.1428571428571	0.00055598029822367	0.126985027546459	1	1	0.999999999716638	0.999999999716637	1
up	MRPS22; MRPS10; MRPS35; MRPS15; MRPS6; MRPS9; MRPL58; MRPL51; MRPL21; MRPL50; GADD45GIP1; MRPL30; CHCHD1; MRPL48; MRPL57; MRPL20; MRPL1; MRPL18; MRPL47; MRPL40; MRPS18A; MRPL39;	GO:0070125~mitochondrial translational elongation	22	89	24.7191011235955	0.0005562200067738	0.126985027546459	1	1	0.999999999716638	0.999999999716637	1
up	MRPS22; MRPS10; MRPS35; MRPS15; MRPS6; MRPS9; MRPL58; MRPL51; MRPL21; MRPL50; GADD45GIP1; MRPL30; CHCHD1; MRPL48; MRPL57; MRPL20; MRPL1; MRPL18; MRPL47; MRPL40; MRPS18A; MRPL39;	GO:0070126~mitochondrial translational termination	22	89	24.7191011235955	0.0005562200067738	0.126985027546459	1	1	0.999999999716638	0.999999999716637	1
down	TGFB1I1; VEGFC; TBX18;	GO:0016331~morphogenesis of embryonic epithelium	3	11	27.2727272727273	0.00061934136065688	0.00767192385436973	1	1	0.448321430373223	0.971764654232744	0.0651192105390188
down	TBX1; LHX1; FOXC2;	GO:0048703~embryonic viscerocranium morphogenesis	3	11	27.2727272727273	0.00061934136065688	0.00767192385436973	1	1	0.448321430373223	0.971764654232744	0.0651192105390188
down	SERPINE2; LIF; NOTCH1;	GO:0048711~positive regulation of astrocyte differentiation	3	11	27.2727272727273	0.00061934136065688	0.00767192385436973	1	1	0.448321430373223	0.971764654232744	0.0651192105390188
down	BMPR1B; THBS1; SFRP1;	GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	3	11	27.2727272727273	0.00061934136065688	0.00767192385436973	1	1	0.448321430373223	0.971764654232744	0.0651192105390188
down	RET; INHBA; SRPX;	GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	3	11	27.2727272727273	0.00061934136065688	0.00767192385436973	1	1	0.448321430373223	0.971764654232744	0.0651192105390188
down	TBX1; SLC26A4; SNAI2; COL2A1; TFAP2A; COL11A1; SIX1; PDZD7;	GO:0007605~sensory perception of sound	8	143	5.59440559440559	0.00062197181651346	0.00767192385436973	1	1	0.449063651522723	0.971764654232744	0.0651192105390188
down	FOXE1; NOTCH1; TGFB2; SHH;	GO:0031069~hair follicle morphogenesis	4	28	14.2857142857143	0.00063356869014707	0.00774488004188762	1	1	0.451817056540689	0.971764654232744	0.0657384619061183
down	SLC26A6; SLC4A3; SLC9A5; SLC9A3;	GO:0051453~regulation of intracellular pH	4	28	14.2857142857143	0.00063356869014707	0.00774488004188762	1	1	0.451817056540689	0.971764654232744	0.0657384619061183
down	COL4A1; COL5A2; MMP2; COL16A1; NTRK2;	GO:0071230~cellular response to amino acid stimulus	5	51	9.80392156862745	0.00064763827851077	0.00788152655009096	1	1	0.455289709793075	0.971764654232744	0.0668983160582221
down	COL4A1; EDNRA; SHH; FOXC2;	GO:0001569~branching involved in blood vessel morphogenesis	4	29	13.7931034482759	0.00071394413366776	0.00857361986069748	1	1	0.468381340693116	0.971764654232744	0.0727727969396196
down	COL2A1; MMP14; MMP16; RUNX2;	GO:0001958~endochondral ossification	4	29	13.7931034482759	0.00071394413366776	0.00857361986069748	1	1	0.468381340693116	0.971764654232744	0.0727727969396196
down	NOTCH1; PKD2; PROX1; SEMA3C;	GO:0021915~neural tube development	4	29	13.7931034482759	0.00071394413366776	0.00857361986069748	1	1	0.468381340693116	0.971764654232744	0.0727727969396196
down	KIF3C; DYNC1H1; KIF26B; WDR63; WDR78; DNAH5;	GO:0007018~microtubule-based movement	6	81	7.40740740740741	0.00075787130640137	0.00904485983041825	1	1	0.475954437485812	0.971764654232744	0.0767726769417092
down	FOSL1; NR2F2; PKD2;	GO:0060674~placenta blood vessel development	3	12	25	0.00076707280576271	0.00904485983041825	1	1	0.4776998559847	0.971764654232744	0.0767726769417092
down	TFPI2; PKD2; HAS2;	GO:0071498~cellular response to fluid shear stress	3	12	25	0.00076707280576271	0.00904485983041825	1	1	0.4776998559847	0.971764654232744	0.0767726769417092
down	TERT; TBX3; HMGA2;	GO:2000648~positive regulation of stem cell proliferation	3	12	25	0.00076707280576271	0.00904485983041825	1	1	0.4776998559847	0.971764654232744	0.0767726769417092
down	APP; SERPINE1; TFPI2; COL7A1; SPOCK1; SERPINB7; SERPINE2; SERPINH1;	GO:0010951~negative regulation of endopeptidase activity	8	148	5.40540540540541	0.00076977530471644	0.00904485983041825	1	1	0.478030464228913	0.971764654232744	0.0767726769417092
down	LHX1; LAMC2; EGFLAM; AGRN;	GO:0008045~motor neuron axon guidance	4	30	13.3333333333333	0.00080126894830545	0.00925533539440963	1	1	0.48354761541021	0.971764654232744	0.0785591913577858
down	HRH1; CAV1; ADRA1B; ADRA1D;	GO:0045907~positive regulation of vasoconstriction	4	30	13.3333333333333	0.00080126894830545	0.00925533539440963	1	1	0.48354761541021	0.971764654232744	0.0785591913577858
down	KCNK2; NTRK1; APOD; FLRT3;	GO:0048678~response to axon injury	4	30	13.3333333333333	0.00080126894830545	0.00925533539440963	1	1	0.48354761541021	0.971764654232744	0.0785591913577858
down	AGRN; FSCN1; PLPPR5; TENM2;	GO:0051491~positive regulation of filopodium assembly	4	30	13.3333333333333	0.00080126894830545	0.00925533539440963	1	1	0.48354761541021	0.971764654232744	0.0785591913577858
down	TBX1; LHX1; SHH; SIX1;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.000895865741106	0.00978940273997321	1	1	0.499893083537151	0.971764654232744	0.0830923494779568
down	PXN; CDH13; LOXL2; TGFB1I1;	GO:0043542~endothelial cell migration	4	31	12.9032258064516	0.000895865741106	0.00978940273997321	1	1	0.499893083537151	0.971764654232744	0.0830923494779568
down	HOXC6; DLX1; NKX3-2; SHH;	GO:0048706~embryonic skeletal system development	4	31	12.9032258064516	0.000895865741106	0.00978940273997321	1	1	0.499893083537151	0.971764654232744	0.0830923494779568
up	MPHOSPH10; NOP56; DKC1; RPP40; SNU13; NOLC1; UTP15; EMG1; RRP36; UTP14A; WDR12; NOL11; UTP3; DDX21; DCAF13; IMP3; LYAR; UTP6; NOB1; WDR3; PA2G4; SBDS; POP5; DDX10; EBNA1BP2; POP4; MRTO4; ESF1; PIH1D2;	GO:0006364~rRNA processing	29	139	20.863309352518	0.00091171018924618	0.18099429235209	1	1	0.999999999716638	0.999999999716637	1
down	SLIT3; NOTCH1; TGFB2;	GO:0003181~atrioventricular valve morphogenesis	3	13	23.0769230769231	0.00093543201595658	0.00992213103306477	1	1	0.506818545088102	0.971764654232744	0.0842189458606087
down	MDK; CDH3; HAS2;	GO:0010838~positive regulation of keratinocyte proliferation	3	13	23.0769230769231	0.00093543201595658	0.00992213103306477	1	1	0.506818545088102	0.971764654232744	0.0842189458606087
down	TFAP2A; INHBA; TWIST1;	GO:0061029~eyelid development in camera-type eye	3	13	23.0769230769231	0.00093543201595658	0.00992213103306477	1	1	0.506818545088102	0.971764654232744	0.0842189458606087
down	FLRT2; COL4A1; CAV1;	GO:0071711~basement membrane organization	3	13	23.0769230769231	0.00093543201595658	0.00992213103306477	1	1	0.506818545088102	0.971764654232744	0.0842189458606087
down	PTK7; SFRP1; VANGL2;	GO:0090179~planar cell polarity pathway involved in neural tube closure	3	13	23.0769230769231	0.00093543201595658	0.00992213103306477	1	1	0.506818545088102	0.971764654232744	0.0842189458606087
down	LPXN; PXN; PTPN14;	GO:1903506~regulation of nucleic acid-templated transcription	3	13	23.0769230769231	0.00093543201595658	0.00992213103306477	1	1	0.506818545088102	0.971764654232744	0.0842189458606087
down	BMPR1B; FSTL1; RUNX2; SMURF2; TGFB2; NODAL;	GO:0030509~BMP signaling pathway	6	85	7.05882352941176	0.00095971072517286	0.0101401993675242	1	1	0.510862807463574	0.971764654232744	0.0860699076340976
down	MAP1B; NCKAP5L; MTCL1; NAV1;	GO:0001578~microtubule bundle formation	4	32	12.5	0.00099805750783699	0.0104241561929641	1	1	0.517572075103809	0.971764654232744	0.088480130239381
down	LIF; AXL; FOXC2; SEMA3C;	GO:0001974~blood vessel remodeling	4	32	12.5	0.00099805750783699	0.0104241561929641	1	1	0.517572075103809	0.971764654232744	0.088480130239381
down	WNT7A; LHX1; SHH; BMPR1B;	GO:0009953~dorsal/ventral pattern formation	4	32	12.5	0.00099805750783699	0.0104241561929641	1	1	0.517572075103809	0.971764654232744	0.088480130239381
down	NTRK1; MMP2; EPHB4; EFNB1; EFNB3; ARHGEF28;	GO:0048013~ephrin receptor signaling pathway	6	86	6.97674418604651	0.00101607834970041	0.0105718686308524	1	1	0.520594663296062	0.971764654232744	0.0897339118885038
down	WNT7A; TGFB1I1; GRK5; PKD2; AMOTL1; FERMT2; MARK1; DKK3; CTNND2;	GO:0016055~Wnt signaling pathway	9	194	4.63917525773196	0.00104120902871729	0.0107921513775032	1	1	0.524769350473516	0.971764654232744	0.0916036695698315
down	PDGFA; CSF3; TGFB2; NTRK2; NTRK1; IGF1R;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	6	87	6.89655172413793	0.00107495309629724	0.0110997050776753	1	1	0.530264608071909	0.971764654232744	0.0942141822044364
down	SFRP1; NODAL; VANGL2;	GO:0048546~digestive tract morphogenesis	3	14	21.4285714285714	0.00112547190371248	0.0114478970504486	1	1	0.538725404540217	0.971764654232744	0.097169632077692
down	VEGFC; ARTN; PGF;	GO:0050930~induction of positive chemotaxis	3	14	21.4285714285714	0.00112547190371248	0.0114478970504486	1	1	0.538725404540217	0.971764654232744	0.097169632077692
down	NOTCH1; TGFB2; FOXC2;	GO:0060038~cardiac muscle cell proliferation	3	14	21.4285714285714	0.00112547190371248	0.0114478970504486	1	1	0.538725404540217	0.971764654232744	0.097169632077692
down	LIF; NR2F2; E2F7;	GO:0060707~trophoblast giant cell differentiation	3	14	21.4285714285714	0.00112547190371248	0.0114478970504486	1	1	0.538725404540217	0.971764654232744	0.097169632077692
down	GDF11; VIM; TGFB2; NODAL; INHBA;	GO:0060395~SMAD protein signal transduction	5	59	8.47457627118644	0.00119215591065602	0.0120760680890095	1	1	0.549481083586561	0.971764654232744	0.102501541373333
down	THBS1; COL4A2; THBS2; TGFB2; HSPG2; ADAMTS1;	GO:0016525~negative regulation of angiogenesis	6	89	6.74157303370786	0.00120051887458605	0.0120760680890095	1	1	0.550732415174063	0.971764654232744	0.102501541373333
down	SERPINE2; LAMA1; LAMA3; FRMD5; AJUBA; AMOTL1;	GO:0030334~regulation of cell migration	6	89	6.74157303370786	0.00120051887458605	0.0120760680890095	1	1	0.550732415174063	0.971764654232744	0.102501541373333
down	COL4A1; TNC; COL4A5; AGRN;	GO:0007528~neuromuscular junction development	4	34	11.7647058823529	0.00122651770366589	0.0122472060812938	1	1	0.554588213184366	0.971764654232744	0.103954158886531
down	MMP2; PXN; PKD2; PTPRK;	GO:0034614~cellular response to reactive oxygen species	4	34	11.7647058823529	0.00122651770366589	0.0122472060812938	1	1	0.554588213184366	0.971764654232744	0.103954158886531
down	FN1; PDGFA; APP; SERPINE1; THBS1; VEGFC; TGFB2;	GO:0002576~platelet degranulation	7	124	5.64516129032258	0.0012797166426517	0.0126854820649764	1	1	0.563075322766746	0.971764654232744	0.107674240915157
down	SLIT3; SERPINE2; INHBA; MYL2; TGFB2; SFRP1; DCBLD2;	GO:0030308~negative regulation of cell growth	7	124	5.64516129032258	0.0012797166426517	0.0126854820649764	1	1	0.563075322766746	0.971764654232744	0.107674240915157
down	NOTCH1; TGFB2; ROBO1;	GO:0003184~pulmonary valve morphogenesis	3	15	20	0.0013381967790892	0.0129819374370005	1	1	0.572498632954444	0.971764654232744	0.110190551054923
down	FGF5; DNER; METRN;	GO:0010001~glial cell differentiation	3	15	20	0.0013381967790892	0.0129819374370005	1	1	0.572498632954444	0.971764654232744	0.110190551054923
down	SNAI2; CD44; TWIST1;	GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator	3	15	20	0.0013381967790892	0.0129819374370005	1	1	0.572498632954444	0.971764654232744	0.110190551054923
down	NTRK1; GDNF; SOX4;	GO:0048485~sympathetic nervous system development	3	15	20	0.0013381967790892	0.0129819374370005	1	1	0.572498632954444	0.971764654232744	0.110190551054923
down	LHX1; FOXL2; TGFB2;	GO:0060065~uterus development	3	15	20	0.0013381967790892	0.0129819374370005	1	1	0.572498632954444	0.971764654232744	0.110190551054923
down	THBS1; NOTCH1; CARD10;	GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis	3	15	20	0.0013381967790892	0.0129819374370005	1	1	0.572498632954444	0.971764654232744	0.110190551054923
down	WNT7A; SHH; KIF26B; FEZ1;	GO:0030010~establishment of cell polarity	4	35	11.4285714285714	0.00135343084241535	0.0130369345456687	1	1	0.574873272879016	0.971764654232744	0.110657365945996
down	TBX3; FOSL1; TGFB2; PROX1;	GO:0045787~positive regulation of cell cycle	4	35	11.4285714285714	0.00135343084241535	0.0130369345456687	1	1	0.574873272879016	0.971764654232744	0.110657365945996
down	RBFOX2; NUAK1; PLAU; MELTF; PKD2; SHH; TGFB2; TFAP2A;	GO:0042127~regulation of cell population proliferation	8	163	4.9079754601227	0.00138912423432114	0.0133336361364768	1	1	0.580627208080864	0.971764654232744	0.113175765988261
down	ADAMTS3; TBX3; FOSL1; EDNRA; PCGF2; NOTCH1; TWIST1; FUT8; TANC2;	GO:0001701~in utero embryonic development	9	203	4.43349753694581	0.00140686958222735	0.0134047135172651	1	1	0.583189132537051	0.971764654232744	0.11377907006322
down	CSF3; LIF; CD44; IL11; KITLG; CNTN1;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	6	92	6.52173913043478	0.00140953552122924	0.0134047135172651	1	1	0.583547705788907	0.971764654232744	0.11377907006322
up	JCHAIN; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; IGHA2; APOB; IGKV3-11; ATP1B1; IGKV4-1; CEACAM5; THBD; CD48; IGLC2; IGLC3; PSG1; SELE; SDC4; CEACAM3; CEACAM6; ATP1B3; CXADR; IGLV3-21; AIMP1; GRB7; ANGPT1; FCAMR; FOXJ1; SIRPG; CD84;	GO:0050900~leukocyte migration	36	193	18.6528497409326	0.00141294250226676	0.241537231374689	1	1	0.999999999716638	0.999999999716637	1
up	PRSS38; PRSS37; TRABD2B; ADAMDEC1; KLK10; TMPRSS11D; KLK8; HP; HPR; LTF; CTSG; CPA3; GZMH; AGA; ENDOU; KEL; PRSS3; GGT5; MMP12; KLK7; GZMK; TMPRSS3; RHBDL3; ADAMTSL3; HTRA3; TMPRSS15; ESPL1; PSMD6; PRSS8; MMEL1; CPZ; PM20D1; GGT6; CASP12; TMPRSS11A; TMPRSS11F; ASRGL1; OVCH1; ADAMTSL2; DPP10; ADGB; ADAMTS14; ATG4A; CAPNS2; PRSS27; TMPRSS13; ADAM33; PRSS22; ADAMTS10; TMPRSS4; RHBDL2; KLK11; FBXO3; KLK12; KLK13; TMPRSS11E; ADAMTS5; KLK5; SPCS1; PGA5; TPSAB1; CPO; TPSB2; PGA3; PGC; CPA4; TPSD1; PRSS21;	GO:0006508~proteolysis	68	436	15.5963302752294	0.00142827534978462	0.241537231374689	1	1	0.999999999716638	0.999999999716637	1
down	FN1; L1CAM; MAP1B; TNFRSF12A;	GO:0045773~positive regulation of axon extension	4	36	11.1111111111111	0.00148922771438909	0.0134047135172651	1	1	0.595857695480173	0.971764654232744	0.11377907006322
down	TERT; DOCK7; ADAMTS1;	GO:1904754~positive regulation of vascular associated smooth muscle cell migration	3	16	18.75	0.00157456362628428	0.0141192777804307	1	1	0.604709893903343	0.971764654232744	0.119844284158148
up	APOA1; APOC3; APOB; APOA4; LPL; GPIHBP1;	GO:0034371~chylomicron remodeling	6	9	66.6666666666667	0.00157848900208657	0.257406456554546	1	1	0.999999999716638	0.999999999716637	1
down	ANO4; ANO1; SLC26A6; TTYH3;	GO:0006821~chloride transport	4	37	10.8108108108108	0.00163422805478985	0.0145585152854809	1	1	0.611201292491406	0.971764654232744	0.123572527570223
down	SNCB; STON2; SYT1; NLGN2;	GO:0048488~synaptic vesicle endocytosis	4	37	10.8108108108108	0.00163422805478985	0.0145585152854809	1	1	0.611201292491406	0.971764654232744	0.123572527570223
down	GJC1; GRIK2; ANO4; ATP13A5; ANO1; TMC7; NALCN; SFXN5; TTYH3;	GO:0034220~ion transmembrane transport	9	208	4.32692307692308	0.00165079032492288	0.014658157738566	1	1	0.612528235504623	0.971764654232744	0.124418291684185
up	KRT33A; KRT37; KRT38; KRT6A; KRT6B; KRT16; KRT3; JUP; DSP; KRT15; KRT4; DSG3; KRT6C; DSG1; DSC2; TGM3; PKP1; KRT32; DSC3; KRT31; LCE3C; LCE3E; LCE3A; KRT79; KRT40; KRT80; KRT77; HRNR; KRT78; KRT35; SPRR4; CNFN; KRTAP3-2; PKP3;	GO:0031424~keratinization	34	181	18.7845303867403	0.001699875711342	0.267642499930606	1	1	0.999999999716638	0.999999999716637	1
down	PDGFA; NTRK1; APP; ALOX15; CD44; NOTCH1; NODAL; CCL26; NTRK2;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	9	209	4.30622009569378	0.00170341230265791	0.0150763049904074	1	1	0.618338665864823	0.971764654232744	0.127967521244572
down	THBS1; INHBA; NOTCH1; MAPK12; TGFB2; PKD2; BTG4;	GO:0007050~cell cycle arrest	7	131	5.34351145038168	0.00172584116517993	0.0152253819297103	1	1	0.620447202274672	0.971764654232744	0.129232884767628
down	DISP2; EVC; SHH; DZIP1; DISP3;	GO:0007224~smoothened signaling pathway	5	65	7.69230769230769	0.00178113991575635	0.0156625400333929	1	1	0.626150554513341	0.971764654232744	0.132943478242344
down	WDR66; DNAH5; WDR78; ZBBX;	GO:0003341~cilium movement	4	38	10.5263157894737	0.00178875000517442	0.0156788826820112	1	1	0.626889345604741	0.971764654232744	0.13308219447524
down	SLC26A4; ANO4; ANO1; SLC26A6; TTYH3; SLC12A4;	GO:1902476~chloride transmembrane transport	6	97	6.18556701030928	0.00181816001688606	0.0158855904039468	1	1	0.629905066617178	0.971764654232744	0.134836727486813
down	COL12A1; COL7A1; MATN3;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	3	17	17.6470588235294	0.0018354833533496	0.0159348013415	1	1	0.631450312094625	0.971764654232744	0.135254429417147
down	PLAU; SERPINE1; PCSK9;	GO:0010469~regulation of signaling receptor activity	3	17	17.6470588235294	0.0018354833533496	0.0159348013415	1	1	0.631450312094625	0.971764654232744	0.135254429417147
up	ALOX15B; MT1A; MT1G; MT1H; MT1X; PTK6; MT1M; PNPT1;	GO:0045926~negative regulation of growth	8	18	44.4444444444444	0.00193443202469834	0.287893612935638	1	1	0.999999999716638	0.999999999716637	1
down	PRRX1; TGFB2; SHH; HOXC10;	GO:0030326~embryonic limb morphogenesis	4	39	10.2564102564103	0.00195310983235897	0.0167955123123361	1	1	0.643907577397392	0.971764654232744	0.142560135259261
down	BMPR1B; TFAP2A; FAM20C; OSR1;	GO:0030501~positive regulation of bone mineralization	4	39	10.2564102564103	0.00195310983235897	0.0167955123123361	1	1	0.643907577397392	0.971764654232744	0.142560135259261
down	THBS1; VEGFC; PRKD1; AMOTL1;	GO:0043536~positive regulation of blood vessel endothelial cell migration	4	39	10.2564102564103	0.00195310983235897	0.0167955123123361	1	1	0.643907577397392	0.971764654232744	0.142560135259261
up	CD5L; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C9; IGKV3-11; IGKV4-1; IGLC2; IGLC3; CD19; IGLV3-21;	GO:0030449~regulation of complement activation	24	113	21.2389380530973	0.00196017630204337	0.287893612935638	1	1	0.999999999716638	0.999999999716637	1
down	NTRK1; IGF1R; GRK5; EPHB4; PRKD1; NTRK2; MEX3B; NEK6;	GO:0046777~protein autophosphorylation	8	173	4.6242774566474	0.00198569883147781	0.0170220597943664	1	1	0.647337819061766	0.971764654232744	0.144483067949868
up	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.00202762181215155	0.287893612935638	1	1	0.999999999716638	0.999999999716637	1
up	A2ML1; CSTA; CSTB; SPINK8; PZP; SERPINB3; PEBP1; SERPINB1; RARRES1; SERPINB8; SPINK7; ITIH3; CST6; SPINK9; CST9; CARD17; ITIH5; NLRP7; CSTL1; FETUB; SERPINB13; UCHL5; SERPINI2; SERPINB4; SERPINA11; SERPINB2; SERPINB12; SERPINB5; SERPINB11;	GO:0010951~negative regulation of endopeptidase activity	29	148	19.5945945945946	0.00208070285301709	0.287893612935638	1	1	0.999999999716638	0.999999999716637	1
down	NEFL; VIM; SHH;	GO:0045109~intermediate filament organization	3	18	16.6666666666667	0.00212182201557498	0.0175144912999316	1	1	0.66061013333227	0.971764654232744	0.148662821489611
down	ITGA2; ADRA1B; ADRA1D;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.00212182201557498	0.0175144912999316	1	1	0.66061013333227	0.971764654232744	0.148662821489611
down	GDF11; FAT1; TENM3;	GO:0048593~camera-type eye morphogenesis	3	18	16.6666666666667	0.00212182201557498	0.0175144912999316	1	1	0.66061013333227	0.971764654232744	0.148662821489611
down	SYT1; GRIK2; CLSTN1;	GO:0050806~positive regulation of synaptic transmission	3	18	16.6666666666667	0.00212182201557498	0.0175144912999316	1	1	0.66061013333227	0.971764654232744	0.148662821489611
down	WNT7A; SHANK3; CTNND2;	GO:0060997~dendritic spine morphogenesis	3	18	16.6666666666667	0.00212182201557498	0.0175144912999316	1	1	0.66061013333227	0.971764654232744	0.148662821489611
down	TGFB1I1; TBX1; COL4A1; CASP6; SIX1;	GO:0030855~epithelial cell differentiation	5	68	7.35294117647059	0.0021445958340931	0.0175144912999316	1	1	0.662539861082998	0.971764654232744	0.148662821489611
down	CLSTN1; MELTF; BCAR1; SPOCK1; PAPPA2;	GO:0001558~regulation of cell growth	5	69	7.2463768115942	0.00227693938984008	0.0178874258694642	1	1	0.671697120002824	0.971764654232744	0.151828286268936
down	CSF2; LIF; ISL1; IL24; IL31RA;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	5	69	7.2463768115942	0.00227693938984008	0.0178874258694642	1	1	0.671697120002824	0.971764654232744	0.151828286268936
down	THBS1; VIM; ITGA2; SOX4; LARP6;	GO:0045727~positive regulation of translation	5	70	7.14285714285714	0.00241512462375959	0.0187462708639655	1	1	0.681562769715758	0.971764654232744	0.159118153723168
down	DLX2; DLX1; OSR1;	GO:0009790~embryo development	3	19	15.7894736842105	0.00243440201241518	0.0187462708639655	1	1	0.683222110660169	0.971764654232744	0.159118153723168
down	ISL1; SOX4; SHH;	GO:0021522~spinal cord motor neuron differentiation	3	19	15.7894736842105	0.00243440201241518	0.0187462708639655	1	1	0.683222110660169	0.971764654232744	0.159118153723168
down	MDK; NOTCH1; SFRP1;	GO:0030279~negative regulation of ossification	3	19	15.7894736842105	0.00243440201241518	0.0187462708639655	1	1	0.683222110660169	0.971764654232744	0.159118153723168
down	BMPR1B; RUNX2; LOXL2;	GO:0032332~positive regulation of chondrocyte differentiation	3	19	15.7894736842105	0.00243440201241518	0.0187462708639655	1	1	0.683222110660169	0.971764654232744	0.159118153723168
down	SERPINE2; RET; ISL1;	GO:0060384~innervation	3	19	15.7894736842105	0.00243440201241518	0.0187462708639655	1	1	0.683222110660169	0.971764654232744	0.159118153723168
down	TERT; HMGA2; TWIST1;	GO:2000773~negative regulation of cellular senescence	3	19	15.7894736842105	0.00243440201241518	0.0187462708639655	1	1	0.683222110660169	0.971764654232744	0.159118153723168
up	CCL21; CCL22; WNT9B; EREG; SIGLEC6; CXCL13; CXCL14; POMC; C1QA; PGR; S100A9; EDN3; NTF3; FGFR3; XCL1; FASLG; CCR5; EFNA3; AFDN; CCL18; CX3CL1; CCL8; PCDH1; AIMP1; IL18; GPNMB; LILRB2; CCL17; TFAP2C; FGF14; FCRL2; TBX5; IL26; STAB1; IL36G; SIRPG; ADRB2; ADRA2C; ADRA2A; FGFBP1;	GO:0007267~cell-cell signaling	40	230	17.3913043478261	0.0024697632352394	0.33167467447362	1	1	0.999999999716638	0.999999999716637	1
down	FGD1; NTRK2; FGD6; BVES; AJUBA;	GO:0043087~regulation of GTPase activity	5	71	7.04225352112676	0.00255929951167833	0.0195973327776267	1	1	0.692019119184558	0.971764654232744	0.166341958467513
down	CDH11; GRIK2; NLGN2; NTNG1; GRIN3B;	GO:0050804~modulation of chemical synaptic transmission	5	71	7.04225352112676	0.00255929951167833	0.0195973327776267	1	1	0.692019119184558	0.971764654232744	0.166341958467513
down	KRT75; KRT8; KRTAP2-3; CDH3; DSG2; LCE1C; LCE1E; LCE1B;	GO:0031424~keratinization	8	181	4.41988950276243	0.00259475690488209	0.0198131857778952	1	1	0.694833264258432	0.971764654232744	0.16817411650724
down	AXL; NOTCH1; PGF; PTPRU;	GO:0031100~animal organ regeneration	4	43	9.30232558139535	0.00271517287160394	0.0206747520893641	1	1	0.703229773745421	0.971764654232744	0.175487082471822
down	CSF2; PKD2; NODAL;	GO:0001892~embryonic placenta development	3	20	15	0.00277400325946286	0.0208317710338726	1	1	0.707370831163031	0.971764654232744	0.17681985765314
down	HOXC11; LAMC1; NOTCH1;	GO:0007492~endoderm development	3	20	15	0.00277400325946286	0.0208317710338726	1	1	0.707370831163031	0.971764654232744	0.17681985765314
down	NTRK1; BCAR1; NTRK2;	GO:0048011~neurotrophin TRK receptor signaling pathway	3	20	15	0.00277400325946286	0.0208317710338726	1	1	0.707370831163031	0.971764654232744	0.17681985765314
down	APP; GRIK2; SYNPO;	GO:0048169~regulation of long-term neuronal synaptic plasticity	3	20	15	0.00277400325946286	0.0208317710338726	1	1	0.707370831163031	0.971764654232744	0.17681985765314
down	WNT7A; ARHGAP22; NRCAM;	GO:0099175~regulation of postsynapse organization	3	20	15	0.00277400325946286	0.0208317710338726	1	1	0.707370831163031	0.971764654232744	0.17681985765314
down	CDH3; CAV1; SOX4; PTK7; SFRP1; SMURF2; LYPD6;	GO:0090263~positive regulation of canonical Wnt signaling pathway	7	144	4.86111111111111	0.00286562365436094	0.0214606870378789	1	1	0.713710169978684	0.971764654232744	0.182158090207797
down	RBFOX2; APP; NEFL; NLGN2;	GO:0050885~neuromuscular process controlling balance	4	44	9.09090909090909	0.00293338228050821	0.0218495420939009	1	1	0.718375633100896	0.971764654232744	0.185458687912222
up	HP; HPR; JCHAIN; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; IGHA2; APOA1; APOB; IGKV3-11; IGKV4-1; ADRB2; IGLC2; IGLC3; FOLR2; FCGR2B; HBA1; IGLV3-21; COLEC12; CLEC9A; FCGR1B; STAB1; CD207;	GO:0006898~receptor-mediated endocytosis	30	160	18.75	0.0031284294887669	0.378293450894437	1	1	0.999999999716638	0.999999999716637	1
down	SNAI2; EDNRA; FOXC2;	GO:0014032~neural crest cell development	3	21	14.2857142857143	0.00314136433521783	0.0221275430951003	1	1	0.725842024069797	0.971764654232744	0.187818357542787
down	FSTL3; MDK; DKK3;	GO:0030325~adrenal gland development	3	21	14.2857142857143	0.00314136433521783	0.0221275430951003	1	1	0.725842024069797	0.971764654232744	0.187818357542787
down	SHH; SFRP1; FOXA2;	GO:0071542~dopaminergic neuron differentiation	3	21	14.2857142857143	0.00314136433521783	0.0221275430951003	1	1	0.725842024069797	0.971764654232744	0.187818357542787
down	NTRK1; SERPINE1; NTRK2; PROX1; HS3ST2;	GO:0007623~circadian rhythm	5	75	6.66666666666667	0.00319886021821292	0.0224744663784753	1	1	0.728344927601072	0.971764654232744	0.190763038793516
up	LGALS3; CCL11; CX3CL1; CCL18; XCL1; XCL2; CCL8; CCL2;	GO:0048245~eosinophil chemotaxis	8	20	40	0.00325021105770307	0.378293450894437	1	1	0.999999999716638	0.999999999716637	1
up	CYP2A6; CYP2C9; CYP4B1; CYP2C19; NUDT15; CYP2F1; CYP2J2; CYP2C18; CYP2G1P;	GO:0042738~exogenous drug catabolic process	9	25	36	0.00325113429702961	0.378293450894437	1	1	0.999999999716638	0.999999999716637	1
up	IRF6; EREG; KLK8; FST; PPARD; SDR16C5;	GO:0043616~keratinocyte proliferation	6	11	54.5454545454545	0.00331400307397667	0.378293450894437	1	1	0.999999999716638	0.999999999716637	1
up	JUP; DSP; DSC2; DLG1; RYR2; CTNNA3;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	6	11	54.5454545454545	0.00331400307397667	0.378293450894437	1	1	0.999999999716638	0.999999999716637	1
down	TERT; KCNK2; TWIST1; SFRP1; SCN2A; TIGAR;	GO:0071456~cellular response to hypoxia	6	111	5.40540540540541	0.0034420956803537	0.0241212154875172	1	1	0.73726063763762	0.971764654232744	0.204740628244636
down	TBX3; ITGA2; CAV1;	GO:0030879~mammary gland development	3	22	13.6363636363636	0.00353718360309263	0.024411044308938	1	1	0.741048618198765	0.971764654232744	0.207200692291235
down	LOXL1; PKD2; ROBO1;	GO:0035904~aorta development	3	22	13.6363636363636	0.00353718360309263	0.024411044308938	1	1	0.741048618198765	0.971764654232744	0.207200692291235
down	APOD; MDK; NOTCH1;	GO:0042246~tissue regeneration	3	22	13.6363636363636	0.00353718360309263	0.024411044308938	1	1	0.741048618198765	0.971764654232744	0.207200692291235
down	FAT1; VANGL2; MTCL1;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	3	22	13.6363636363636	0.00353718360309263	0.024411044308938	1	1	0.741048618198765	0.971764654232744	0.207200692291235
down	NOTCH1; MMP14; SHH;	GO:0048754~branching morphogenesis of an epithelial tube	3	22	13.6363636363636	0.00353718360309263	0.024411044308938	1	1	0.741048618198765	0.971764654232744	0.207200692291235
down	MDK; PROX1; DISP3;	GO:2000179~positive regulation of neural precursor cell proliferation	3	22	13.6363636363636	0.00353718360309263	0.024411044308938	1	1	0.741048618198765	0.971764654232744	0.207200692291235
down	APP; RAG1; HRH1; SYNPO;	GO:0008542~visual learning	4	47	8.51063829787234	0.00365928303028218	0.0250633305038925	1	1	0.74589540778423	0.971764654232744	0.212737290785594
down	LIF; TGFB2; TENM3; TENM2;	GO:0048666~neuron development	4	47	8.51063829787234	0.00365928303028218	0.0250633305038925	1	1	0.74589540778423	0.971764654232744	0.212737290785594
down	NOTCH1; DOCK7; FOXC2; HOXC10;	GO:0120163~negative regulation of cold-induced thermogenesis	4	47	8.51063829787234	0.00365928303028218	0.0250633305038925	1	1	0.74589540778423	0.971764654232744	0.212737290785594
down	TGFB2; TEAD2; TWIST1; DLC1; VANGL2;	GO:0001843~neural tube closure	5	78	6.41025641025641	0.00374868528889727	0.0256113185401854	1	1	0.749326057202749	0.971764654232744	0.217388607585081
down	INHBA; NODAL; TGFB2; GDF11;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	4	48	8.33333333333333	0.00392598248422149	0.0261685140617839	1	1	0.755755758209715	0.971764654232744	0.222118077424867
down	FLRT2; RBFOX2; FRS3; FGF5; FLRT3;	GO:0008543~fibroblast growth factor receptor signaling pathway	5	79	6.32911392405063	0.00394611186766014	0.0261685140617839	1	1	0.756722002702413	0.971764654232744	0.222118077424867
up	CCL21; CXCL13; OXSR1; S100A7; CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	7	16	43.75	0.00395177580156281	0.432971798589072	1	1	0.999999999716638	0.999999999716637	1
down	NOTCH1; VEGFC; SHH;	GO:0002052~positive regulation of neuroblast proliferation	3	23	13.0434782608696	0.00396212030968435	0.0261685140617839	1	1	0.75676497914971	0.971764654232744	0.222118077424867
down	GRIN3B; APP; GRIK2;	GO:0035235~ionotropic glutamate receptor signaling pathway	3	23	13.0434782608696	0.00396212030968435	0.0261685140617839	1	1	0.75676497914971	0.971764654232744	0.222118077424867
down	TBX1; PRRX1; FOXC2;	GO:0048844~artery morphogenesis	3	23	13.0434782608696	0.00396212030968435	0.0261685140617839	1	1	0.75676497914971	0.971764654232744	0.222118077424867
down	NTRK1; NLGN2; SHANK3;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	3	23	13.0434782608696	0.00396212030968435	0.0261685140617839	1	1	0.75676497914971	0.971764654232744	0.222118077424867
down	NOTCH1; PRRX1; PROX1;	GO:0097150~neuronal stem cell population maintenance	3	23	13.0434782608696	0.00396212030968435	0.0261685140617839	1	1	0.75676497914971	0.971764654232744	0.222118077424867
down	KCNU1; NALCN; KCNA7; SCN2A; KCNF1; KCNJ12;	GO:0034765~regulation of ion transmembrane transport	6	115	5.21739130434783	0.00405918802056371	0.0261685140617839	1	1	0.760715813272231	0.971764654232744	0.222118077424867
up	CYP2C9; CYP2C19; CYP2J2; CYP4A11; CYP2G1P; CYP2F1; CYP2C18; CYP2A6;	GO:0019373~epoxygenase P450 pathway	8	21	38.0952380952381	0.00412559132249168	0.432971798589072	1	1	0.999999999716638	0.999999999716637	1
up	PLA2G4B; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G12A;	GO:0036150~phosphatidylserine acyl-chain remodeling	8	21	38.0952380952381	0.00412559132249168	0.432971798589072	1	1	0.999999999716638	0.999999999716637	1
up	ARPC3; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; IGHG2; IGHG3; IGHG4; IGKV3-11; IGKV4-1; CD3G; IGLC2; IGLC3; FCGR2A; NCK1; FCGR2B; NCKAP1L; IGLV3-21; BRK1; BAIAP2;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	26	135	19.2592592592593	0.00417230817738046	0.432971798589072	1	1	0.999999999716638	0.999999999716637	1
down	NUAK1; RET; LAMA1; LAMA3;	GO:0030155~regulation of cell adhesion	4	49	8.16326530612245	0.0042055259327386	0.0269747381003421	1	1	0.766017941097679	0.971764654232744	0.228961298747846
down	MAPK11; SFRP1; HAS2; ADAMTS7; CCL26;	GO:0071347~cellular response to interleukin-1	5	81	6.17283950617284	0.00436307523611468	0.0279195847268747	1	1	0.772264316792298	0.971764654232744	0.236981147167641
down	ONECUT2; SOX4; FOXA2;	GO:0031018~endocrine pancreas development	3	24	12.5	0.0044167956592871	0.0280656992242812	1	1	0.774086396484231	0.971764654232744	0.238221365514437
down	WDR54; NTRK1; NTRK2;	GO:0043408~regulation of MAPK cascade	3	24	12.5	0.0044167956592871	0.0280656992242812	1	1	0.774086396484231	0.971764654232744	0.238221365514437
down	FSTL3; FBN1; SFRP1;	GO:0045671~negative regulation of osteoclast differentiation	3	24	12.5	0.0044167956592871	0.0280656992242812	1	1	0.774086396484231	0.971764654232744	0.238221365514437
down	PDGFA; FGD1; FSCN1; FGD6; DLC1; MICAL3; AMOTL1;	GO:0030036~actin cytoskeleton organization	7	157	4.45859872611465	0.00450865248237509	0.0285827596905918	1	1	0.777800447376453	0.971764654232744	0.242610169418938
down	NEFL; CRMP1; MAP6; DOCK7; MARK1; MAP1B;	GO:0000226~microtubule cytoskeleton organization	6	118	5.08474576271187	0.00457301468002147	0.0289189776189679	1	1	0.780369565286863	0.971764654232744	0.245463983726863
up	CCL22; DEFB4A; CXCL14; RNASE2; CCL2; FPR3; CCL11; NCKAP1L; CCL18; DEFB1; CX3CL1; CCL8; AIMP1; PLD1; RALBP1; ECSCR; CMTM8; CCL17; RARRES2; CXCR3; CCR8; CCR2; ACKR2; CCR5;	GO:0006935~chemotaxis	24	122	19.672131147541	0.00458178912388274	0.464898869769969	1	1	0.999999999716638	0.999999999716637	1
down	PLOD2; LOX; FBXO2; FBXL2; LOXL2;	GO:0006464~cellular protein modification process	5	82	6.09756097560976	0.00458290474372491	0.0289189776189679	1	1	0.780369565286863	0.971764654232744	0.245463983726863
down	KCNK2; ITGA3; HRH1; SCN2A; SHANK3;	GO:0007613~memory	5	83	6.02409638554217	0.00481049368710018	0.0302850018268709	1	1	0.78892096468443	0.971764654232744	0.25705878311283
up	DKK1; C1QA; C1QB; C1QC; CX3CL1;	GO:0098883~synapse pruning	5	8	62.5	0.00481679143916725	0.478118906766036	1	1	0.999999999716638	0.999999999716637	1
down	AGRN; HSPG2; GPC6;	GO:0006027~glycosaminoglycan catabolic process	3	25	12	0.00490179386531575	0.0306474543047035	1	1	0.792956171178587	0.971764654232744	0.26013527600593
down	SEMA4F; SEMA6D; SEMA3C;	GO:0048843~negative regulation of axon extension involved in axon guidance	3	25	12	0.00490179386531575	0.0306474543047035	1	1	0.792956171178587	0.971764654232744	0.26013527600593
down	FLRT3; NTNG1; GPC6;	GO:0099560~synaptic membrane adhesion	3	25	12	0.00490179386531575	0.0306474543047035	1	1	0.792956171178587	0.971764654232744	0.26013527600593
down	TFAP2A; TGFB2; GRIK2; PCSK9;	GO:0043525~positive regulation of neuron apoptotic process	4	52	7.69230769230769	0.00512400238668564	0.0307586942137545	1	1	0.799806530922497	0.971764654232744	0.2610794792065
down	SH3PXD2B; PXN; SFRP1; FHOD1;	GO:0051496~positive regulation of stress fiber assembly	4	52	7.69230769230769	0.00512400238668564	0.0307586942137545	1	1	0.799806530922497	0.971764654232744	0.2610794792065
up	GCAT; DDC; GGT5; PTS; PM20D1; KYAT3; PHGDH;	GO:0006520~cellular amino acid metabolic process	7	17	41.1764705882353	0.00513474063070318	0.498834589782782	1	1	0.999999999716638	0.999999999716637	1
down	RGS3; CAV1; SPRED3;	GO:0000188~inactivation of MAPK activity	3	26	11.5384615384615	0.00541766317852432	0.0318287711738304	1	1	0.807231813600124	0.971764654232744	0.270162281405645
down	APP; ITGA3; VANGL2;	GO:0030111~regulation of Wnt signaling pathway	3	26	11.5384615384615	0.00541766317852432	0.0318287711738304	1	1	0.807231813600124	0.971764654232744	0.270162281405645
down	DSCAM; APP; THBS1;	GO:0042327~positive regulation of phosphorylation	3	26	11.5384615384615	0.00541766317852432	0.0318287711738304	1	1	0.807231813600124	0.971764654232744	0.270162281405645
down	WNT7A; NLGN2; SHANK3;	GO:2000463~positive regulation of excitatory postsynaptic potential	3	26	11.5384615384615	0.00541766317852432	0.0318287711738304	1	1	0.807231813600124	0.971764654232744	0.270162281405645
down	EFNB1; CAV1; EFNB3; PDCD1LG2;	GO:0031295~T cell costimulation	4	53	7.54716981132075	0.00545768156093973	0.0319262659551968	1	1	0.80790536985957	0.971764654232744	0.270989816104212
down	CAV1; SOX4; SH3RF2; RASD2;	GO:0031397~negative regulation of protein ubiquitination	4	53	7.54716981132075	0.00545768156093973	0.0319262659551968	1	1	0.80790536985957	0.971764654232744	0.270989816104212
down	CSF2; SERPINE1; VIM; CSF3; AXL; IL24; PDCD1LG2;	GO:0071222~cellular response to lipopolysaccharide	7	163	4.29447852760736	0.00547077631642068	0.0319343388406055	1	1	0.808609012017858	0.971764654232744	0.271058338672288
down	PTHLH; FOSL1; ITGA2; PGF; COL16A1;	GO:0007565~female pregnancy	5	86	5.81395348837209	0.00554126226983742	0.0322766686914034	1	1	0.809323479440119	0.971764654232744	0.273964030914685
down	APP; CPS1; PKD2; SLC26A6;	GO:0071320~cellular response to cAMP	4	54	7.40740740740741	0.00580556173996782	0.0337440539512842	1	1	0.813852281003806	0.971764654232744	0.286419181864287
down	THBS1; POSTN; SFRP1; HAS2; ADAMTS7; CCL26;	GO:0071356~cellular response to tumor necrosis factor	6	125	4.8	0.00595625971878944	0.0345230646551196	1	1	0.816285108290084	0.971764654232744	0.293031416682848
down	ITGB4; MMP14; FSCN1;	GO:0048870~cell motility	3	27	11.1111111111111	0.00596491689382295	0.0345230646551196	1	1	0.817123082133136	0.971764654232744	0.293031416682848
down	TBX1; MAPK12; EVC; TWIST1; BVES;	GO:0007517~muscle organ development	5	89	5.61797752808989	0.00634703548152082	0.0360202598218356	1	1	0.823404178107158	0.971764654232744	0.305739593814173
up	FABP12; APOC3; APOB; LPL; FABP1; FABP2; FABP5; MGLL;	GO:0019433~triglyceride catabolic process	8	23	34.7826086956522	0.00640894628474209	0.596088397694545	1	1	0.999999999716638	0.999999999716637	1
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.00652746821829331	0.596088397694545	1	1	0.999999999716638	0.999999999716637	1
down	SHANK3; ADRA1D; ADRA1B;	GO:0007610~behavior	3	28	10.7142857142857	0.00654403433443229	0.0364061991748213	1	1	0.826340794406701	0.971764654232744	0.309015443061303
down	ISL1; CCBE1; NODAL;	GO:0010575~positive regulation of vascular endothelial growth factor production	3	28	10.7142857142857	0.00654403433443229	0.0364061991748213	1	1	0.826340794406701	0.971764654232744	0.309015443061303
down	TERT; LOX; POLM;	GO:0071897~DNA biosynthetic process	3	28	10.7142857142857	0.00654403433443229	0.0364061991748213	1	1	0.826340794406701	0.971764654232744	0.309015443061303
down	LCAT; PLPP4; PCSK9; PLPPR5;	GO:0006644~phospholipid metabolic process	4	57	7.01754385964912	0.00693695559389451	0.0385135253542901	1	1	0.83272228751917	0.971764654232744	0.326902405935296
down	RAG1; SHH; FZD8;	GO:0033077~T cell differentiation in thymus	3	29	10.3448275862069	0.00715546181480631	0.0394056341558828	1	1	0.837189032332338	0.971764654232744	0.334474616240999
down	NTRK1; KITLG; NOTCH1;	GO:0046579~positive regulation of Ras protein signal transduction	3	29	10.3448275862069	0.00715546181480631	0.0394056341558828	1	1	0.837189032332338	0.971764654232744	0.334474616240999
down	NOTCH1; NTRK2; SHH;	GO:0048709~oligodendrocyte differentiation	3	29	10.3448275862069	0.00715546181480631	0.0394056341558828	1	1	0.837189032332338	0.971764654232744	0.334474616240999
down	WNT7A; APP; GPC6;	GO:1905606~regulation of presynapse assembly	3	29	10.3448275862069	0.00715546181480631	0.0394056341558828	1	1	0.837189032332338	0.971764654232744	0.334474616240999
up	CCL21; RAMP3; EGFR; PLA2G2A; FGFR3; FSHR; S100A7; FLT4; CHRNA7; PLA2G5; CASR; CX3CL1; SLAMF1; GPNMB; ANGPT1; SYT14P1; TNFAIP8L3; FFAR4; SCIMP; NPNT; SLC30A10; CCL19; GAREM1; IL26; GPR55; CCL8; CCL11; CCL17; HMGB1P1; XCL1; CCL22; CCL14; CCL2; XCL2; CCL18;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	35	209	16.7464114832536	0.00729269673413668	0.640354870924386	1	1	0.999999999716638	0.999999999716637	1
down	COL4A1; APOD; SYT1; PTPRG; HSPG2; DLX2; PROX1; NODAL;	GO:0007420~brain development	8	217	3.68663594470046	0.00732100347380071	0.0402359989306063	1	1	0.839885187951533	0.971764654232744	0.341522743883534
down	GDF11; APP; ISL1; DISP3;	GO:0045665~negative regulation of neuron differentiation	4	59	6.77966101694915	0.00776680403051744	0.0414526603246897	1	1	0.846581639326401	0.971764654232744	0.351849753246497
down	TBX1; GDF11; FOXC2;	GO:0007498~mesoderm development	3	30	10	0.00779961358301096	0.0414526603246897	1	1	0.847982379744638	0.971764654232744	0.351849753246497
down	TFAP2A; HAS2; PAPPA2;	GO:0060349~bone morphogenesis	3	30	10	0.00779961358301096	0.0414526603246897	1	1	0.847982379744638	0.971764654232744	0.351849753246497
down	TERT; SERPINE1; IL11;	GO:2000352~negative regulation of endothelial cell apoptotic process	3	30	10	0.00779961358301096	0.0414526603246897	1	1	0.847982379744638	0.971764654232744	0.351849753246497
up	PLA2G2A; BDKRB2; PLA2G4A; PLA2G4F; PLA2G12A; PLA2G3; ANXA1; PLA2G5;	GO:0050482~arachidonic acid secretion	8	24	33.3333333333333	0.00785776634813162	0.664417798992018	1	1	0.999999999716638	0.999999999716637	1
down	COL2A1; SHH; DNER; NRCAM; TAGLN3; TBX3;	GO:0007417~central nervous system development	6	133	4.51127819548872	0.00788451179061267	0.0418155236210314	1	1	0.849435721861349	0.971764654232744	0.354929733162864
up	CCL2; LGALS3; EDN2; EDNRB; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	6	14	42.8571428571429	0.00813125826775762	0.67435439934511	1	1	0.999999999716638	0.999999999716637	1
down	HRH1; ANO1; ADRA1D; ADRA1B;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	4	60	6.66666666666667	0.0082051139049506	0.0432633278624668	1	1	0.853993931227398	0.971764654232744	0.367218680629882
down	PDGFA; KITLG; AJUBA; ROBO1;	GO:0043406~positive regulation of MAP kinase activity	4	60	6.66666666666667	0.0082051139049506	0.0432633278624668	1	1	0.853993931227398	0.971764654232744	0.367218680629882
down	BMPR1B; RUNX2; PRKD1; FAM20C;	GO:0045669~positive regulation of osteoblast differentiation	4	60	6.66666666666667	0.0082051139049506	0.0432633278624668	1	1	0.853993931227398	0.971764654232744	0.367218680629882
up	PLA2G2A; PLA2G5; PLA2G4A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G12A;	GO:0036149~phosphatidylinositol acyl-chain remodeling	7	19	36.8421052631579	0.00827066280405742	0.67435439934511	1	1	0.999999999716638	0.999999999716637	1
down	THBS1; NR2F2; CAV1;	GO:0001937~negative regulation of endothelial cell proliferation	3	31	9.67741935483871	0.00847687274121922	0.0445239982515676	1	1	0.858873896548698	0.971764654232744	0.377919237888595
down	CDK5R2; PKD2; PROX1;	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	3	31	9.67741935483871	0.00847687274121922	0.0445239982515676	1	1	0.858873896548698	0.971764654232744	0.377919237888595
down	SLC26A4; SLC9A3; SLC9A5; SLC26A6; SLC12A4;	GO:0006811~ion transport	5	96	5.20833333333333	0.00854003144173265	0.0447694725195446	1	1	0.860578011422802	0.971764654232744	0.380002820943085
up	PIR; ALPI; PGA3; PGA5; PGC; PRSS3; AKR1C2; GKN1; CYP39A1;	GO:0007586~digestion	9	30	30	0.00858701304246046	0.676005199170249	1	1	0.999999999716638	0.999999999716637	1
down	VIM; PTPRG; SPOCK1; CRMP1;	GO:0010977~negative regulation of neuron projection development	4	61	6.55737704918033	0.00865931718146318	0.0453076749264273	1	1	0.862323189305921	0.971764654232744	0.384571077421079
down	APP; FOSL1; NTRK2; SHANK3;	GO:0007612~learning	4	62	6.45161290322581	0.0091296342181002	0.0469580210474544	1	1	0.869745718023998	0.971764654232744	0.398579198272827
down	NEFL; SOX4; PKD2;	GO:0021510~spinal cord development	3	32	9.375	0.00918759214741827	0.0469580210474544	1	1	0.871720300984255	0.971764654232744	0.398579198272827
down	SEMA4F; SEMA6D; SEMA3C;	GO:0071526~semaphorin-plexin signaling pathway	3	32	9.375	0.00918759214741827	0.0469580210474544	1	1	0.871720300984255	0.971764654232744	0.398579198272827
up	IL2RA; IL20RB; IL36A; IL1RN; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	8	25	32	0.0095391077999939	0.704927606641043	1	1	0.999999999716638	0.999999999716637	1
down	WNT7A; SOX4; SFRP1; VANGL2;	GO:0035019~somatic stem cell population maintenance	4	63	6.34920634920635	0.00961627980470825	0.0485444050882124	1	1	0.877959983138669	0.971764654232744	0.412044409647027
down	SH3PXD2B; HOXC8; NKX3-2;	GO:0048705~skeletal system morphogenesis	3	33	9.09090909090909	0.00993209529646899	0.0499536748674806	1	1	0.88395648138574	0.971764654232744	0.424006276996658
down	TERT; MMP2; ADAMTS1;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	3	33	9.09090909090909	0.00993209529646899	0.0499536748674806	1	1	0.88395648138574	0.971764654232744	0.424006276996658
up	APOA1; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.0100804190758161	0.704927606641043	1	1	0.999999999716638	0.999999999716637	1
up	TCF21; ID1; FOXF1; ERRFI1;	GO:0060426~lung vasculature development	4	6	66.6666666666667	0.0100804190758161	0.704927606641043	1	1	0.999999999716638	0.999999999716637	1
up	JUP; DSP; DSC2; CTNNA3;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	4	6	66.6666666666667	0.0100804190758161	0.704927606641043	1	1	0.999999999716638	0.999999999716637	1
up	JCHAIN; IGKV3-20; IGHA2; LTF; CTSG; H2BFS; DEFB1; RNASE6; RNASE7;	GO:0019731~antibacterial humoral response	9	31	29.0322580645161	0.0101807521756299	0.704927606641043	1	1	0.999999999716638	0.999999999716637	1
up	EDN3; EDN2; AVPR1A; NMU; RGS4; KCNQ1; RYR2;	GO:0010460~positive regulation of heart rate	7	20	35	0.010281270674668	0.704927606641043	1	1	0.999999999716638	0.999999999716637	1
up	GGCT; GGT5; GGT6; CHAC2; MGST2; CHAC1;	GO:0006750~glutathione biosynthetic process	6	15	40	0.010498264838281	0.704927606641043	1	1	0.999999999716638	0.999999999716637	1
up	PLA2G4B; PLA2G4D; GDPD3; PLA2G4A; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	6	15	40	0.010498264838281	0.704927606641043	1	1	0.999999999716638	0.999999999716637	1
up	CCL22; EREG; F13A1; POMC; IL2RA; IGHG4; ANXA1; CCL2; MUC1; IL1RN; EDN2; IL10; PTPRZ1; CD80; FLT3; CCR2; TEC; FASLG; CEBPA; RORC; CCL11; CCR5; YWHAZ; CX3CL1; LCN2; IL18; IRF4; BATF; IL20RB; IL17REL; IL22RA1; IL1F10; IL22RA2; IL17F; CCL19; IL1RL2; IL23A; IL26; IL36B; IL36G; IL36RN; IL36A; IL20RA;	GO:0019221~cytokine-mediated signaling pathway	43	278	15.4676258992806	0.0107060943897299	0.708464159181258	1	1	0.999999999716638	0.999999999716637	1
down	SHH; SIX1; SIX4;	GO:0034504~protein localization to nucleus	3	34	8.82352941176471	0.0107106771814527	0.0531699553950895	1	1	0.897091148203402	0.971764654232744	0.451306032938659
down	PDGFA; COL5A2; ITGA3;	GO:0043588~skin development	3	34	8.82352941176471	0.0107106771814527	0.0531699553950895	1	1	0.897091148203402	0.971764654232744	0.451306032938659
down	RBFOX2; DSCAM; MAP6;	GO:0048813~dendrite morphogenesis	3	34	8.82352941176471	0.0107106771814527	0.0531699553950895	1	1	0.897091148203402	0.971764654232744	0.451306032938659
down	CEP290; ONECUT2; NOTCH1; ARMC9; DZIP1; DNAH5; CFAP54;	GO:0060271~cilium assembly	7	187	3.74331550802139	0.01090693834736	0.0531883970212941	1	1	0.899074512986844	0.971764654232744	0.451462565271656
down	ITGA2; ITGA3; TGFB2;	GO:0010634~positive regulation of epithelial cell migration	3	35	8.57142857142857	0.0115236051367049	0.0559952720189975	1	1	0.907608991751962	0.971764654232744	0.47528729129889
down	NTRK1; APP; NTRK2;	GO:1990090~cellular response to nerve growth factor stimulus	3	35	8.57142857142857	0.0115236051367049	0.0559952720189975	1	1	0.907608991751962	0.971764654232744	0.47528729129889
down	TERT; SHH; SFRP1;	GO:0030177~positive regulation of Wnt signaling pathway	3	36	8.33333333333333	0.0123711196613205	0.0595013059571965	1	1	0.917244693583547	0.971764654232744	0.505046471201136
down	TFAP2A; LIF; RUNX2;	GO:0045595~regulation of cell differentiation	3	36	8.33333333333333	0.0123711196613205	0.0595013059571965	1	1	0.917244693583547	0.971764654232744	0.505046471201136
down	GJC1; PXN; MYL7; CALD1; KCNJ12;	GO:0006936~muscle contraction	5	106	4.71698113207547	0.0125078483200549	0.0595013059571965	1	1	0.919851071947828	0.971764654232744	0.505046471201136
up	CYP2F1; CYP2J2; CYP2C19; CYP2A6; CYP2C9; CYP2G1P; CYP2C18;	GO:0006082~organic acid metabolic process	7	21	33.3333333333333	0.0126249572137277	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CLDN5; CLDN4; CLDN7; CLDN1; CLDN8; CLDN17; CLDN10;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	7	21	33.3333333333333	0.0126249572137277	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	S100A8; S100A9; SELE; CX3CL1; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	5	11	45.4545454545455	0.0128959954755619	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.0131322466303245	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CCL21; IGF1; CCL19;	GO:0010560~positive regulation of glycoprotein biosynthetic process	3	3	100	0.0131322466303245	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021912~regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification	3	3	100	0.0131322466303245	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	TGM1; TGM3; HRNR;	GO:0043163~cell envelope organization	3	3	100	0.0131322466303245	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	HTRA1; E2F7; NODAL;	GO:0001890~placenta development	3	37	8.10810810810811	0.0132534352243963	0.0623987295711644	1	1	0.92820945773673	0.971764654232744	0.529639772949203
down	ALOX15; ITGA3; EGFLAM;	GO:0010811~positive regulation of cell-substrate adhesion	3	37	8.10810810810811	0.0132534352243963	0.0623987295711644	1	1	0.92820945773673	0.971764654232744	0.529639772949203
up	PTGES; EDN2; PLA2G4A; PTGIS; PLA2G4F; MGST1;	GO:0001516~prostaglandin biosynthetic process	6	16	37.5	0.0133148526920041	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A;	GO:0030889~negative regulation of B cell proliferation	6	16	37.5	0.0133148526920041	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	TERT; APP; CSF3; CAV1;	GO:0032092~positive regulation of protein binding	4	70	5.71428571428571	0.0134968482691167	0.0633260040991602	1	1	0.931282530569051	0.971764654232744	0.537510469577876
down	WNT7A; SHH; SFRP1; FZD8;	GO:0060070~canonical Wnt signaling pathway	4	70	5.71428571428571	0.0134968482691167	0.0633260040991602	1	1	0.931282530569051	0.971764654232744	0.537510469577876
down	SLC4A3; SLC9A3; SLC9A5;	GO:0098656~anion transmembrane transport	3	38	7.89473684210526	0.0141707410535975	0.065378436211754	1	1	0.939208114784771	0.971764654232744	0.554931492178473
up	PTGES; CXCL13; S100A8; CCL11;	GO:0002544~chronic inflammatory response	4	7	57.1428571428571	0.0146820175121798	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	SLC22A3; POMC; SCTR; HTR4;	GO:0032098~regulation of appetite	4	7	57.1428571428571	0.0146820175121798	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	S100A8; SERPINB3; CX3CL1; HILPDA;	GO:0035425~autocrine signaling	4	7	57.1428571428571	0.0146820175121798	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.0146820175121798	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	KLF4; IFNG; PAX6; FOXC1;	GO:1904798~positive regulation of core promoter binding	4	7	57.1428571428571	0.0146820175121798	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	NTRK1; RAG1; IL11; POLM;	GO:0030183~B cell differentiation	4	72	5.55555555555556	0.0147634969067245	0.0668526454613472	1	1	0.944863802030369	0.971764654232744	0.567444565082365
up	KRT16; KRT3; KRT6C; EVPLL; PPL; DSP; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	7	22	31.8181818181818	0.0153293009063532	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	TNFRSF10B; LOX; CASP6; BCAR1; BCL2L15; RTKN; CARD10;	GO:0042981~regulation of apoptotic process	7	202	3.46534653465347	0.015848759944548	0.0713803877359199	1	1	0.953765301408875	0.971764654232744	0.605875994804699
down	CAV1; TNS4; NRCAM; CCDC68;	GO:0008104~protein localization	4	74	5.40540540540541	0.0161027822637301	0.0713803877359199	1	1	0.956524506716711	0.971764654232744	0.605875994804699
down	TNFRSF10B; THBS1; ALOX15; SRPX;	GO:0034976~response to endoplasmic reticulum stress	4	74	5.40540540540541	0.0161027822637301	0.0713803877359199	1	1	0.956524506716711	0.971764654232744	0.605875994804699
down	ITGA2; DZIP1; PDZD7;	GO:0045184~establishment of protein localization	3	40	7.5	0.016110958808899	0.0713803877359199	1	1	0.956524506716711	0.971764654232744	0.605875994804699
down	KRT8; FHOD3; SIX4;	GO:0045214~sarcomere organization	3	40	7.5	0.016110958808899	0.0713803877359199	1	1	0.956524506716711	0.971764654232744	0.605875994804699
down	APP; GRIK2; SCN2A;	GO:0051402~neuron apoptotic process	3	40	7.5	0.016110958808899	0.0713803877359199	1	1	0.956524506716711	0.971764654232744	0.605875994804699
up	IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-47; IGLV2-14; IGLV2-23; IGLV3-1; IGLV3-25; IGHV3-23; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C9; IGKV3-11; IGKV4-1; IGLC2; IGLC3; IGLV3-21; TRDC; IGHV3-21; TRBC2; TRBC1; IGHA2;	GO:0006958~complement activation, classical pathway	27	161	16.7701863354037	0.016505215738242	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	TERT; SLIT3; APP; NOTCH1; TGFB2; SFRP1; ROBO1;	GO:0010629~negative regulation of gene expression	7	204	3.43137254901961	0.0166104233904406	0.0724480226597458	1	1	0.962380779206814	0.971764654232744	0.614938069025343
up	RRP15; WDR12; MRPL1; SNU13; RSL1D1; MAK16;	GO:0000470~maturation of LSU-rRNA	6	17	35.2941176470588	0.0166194680650639	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	ALOX15B; APOB; LPL; PLA2G2A; PLA2G5; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	6	17	35.2941176470588	0.0166194680650639	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	PDPN; SFXN5; SLC38A5;	GO:0006865~amino acid transport	3	41	7.31707317073171	0.0171341298198711	0.0743752195684212	1	1	0.964572845290641	0.971764654232744	0.631296096506899
down	CPS1; FSTL1; TBC1D5;	GO:0042594~response to starvation	3	41	7.31707317073171	0.0171341298198711	0.0743752195684212	1	1	0.964572845290641	0.971764654232744	0.631296096506899
down	NTRK1; APP; IGF1R;	GO:1904646~cellular response to amyloid-beta	3	41	7.31707317073171	0.0171341298198711	0.0743752195684212	1	1	0.964572845290641	0.971764654232744	0.631296096506899
down	TBX1; NTRK1; APP; NTRK2; PGF; VEGFC;	GO:0001934~positive regulation of protein phosphorylation	6	161	3.72670807453416	0.0181584102006019	0.0757121574603186	1	1	0.966525421900541	0.971764654232744	0.642644011542639
down	SLC26A4; SLC4A3; SLC26A6;	GO:0015701~bicarbonate transport	3	42	7.14285714285714	0.0181928107210588	0.0757121574603186	1	1	0.966525421900541	0.971764654232744	0.642644011542639
down	ISL1; SOX4; NLGN2;	GO:0032024~positive regulation of insulin secretion	3	42	7.14285714285714	0.0181928107210588	0.0757121574603186	1	1	0.966525421900541	0.971764654232744	0.642644011542639
down	MMP14; DLX1; DLX2;	GO:0045746~negative regulation of Notch signaling pathway	3	42	7.14285714285714	0.0181928107210588	0.0757121574603186	1	1	0.966525421900541	0.971764654232744	0.642644011542639
down	LYPD6; PCSK9; DKK3;	GO:2000272~negative regulation of signaling receptor activity	3	42	7.14285714285714	0.0181928107210588	0.0757121574603186	1	1	0.966525421900541	0.971764654232744	0.642644011542639
down	CDH13; PDPN; RTKN; VANGL2;	GO:0007266~Rho protein signal transduction	4	77	5.19480519480519	0.0182504699487651	0.0757121574603186	1	1	0.967227328525014	0.971764654232744	0.642644011542639
down	PDGFA; FSCN1; DLC1; VANGL2;	GO:0032956~regulation of actin cytoskeleton organization	4	77	5.19480519480519	0.0182504699487651	0.0757121574603186	1	1	0.967227328525014	0.971764654232744	0.642644011542639
up	CLDN1; ASS1; GBA; APOB; CCL2; PCK1; CEBPA; LCN2; HYAL1; OCLN; NPNT; XCL2; CCL22; CCL8; CX3CL1; CCL17; CCL14; CCL21; CCL19; CCL18; CCL11; XCL1;	GO:0071356~cellular response to tumor necrosis factor	22	125	17.6	0.0184672493213253	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CD5L; RAET1L; CD300LG; IDO2; CD300LF; IRF6; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	9	35	25.7142857142857	0.0188380744657115	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	TBX3; TBX1; ANTXR1;	GO:0001568~blood vessel development	3	43	6.97674418604651	0.019287075733366	0.0757121574603186	1	1	0.968717089523898	0.971764654232744	0.642644011542639
down	FSD1; DYNC1H1; KATNAL1;	GO:0031122~cytoplasmic microtubule organization	3	43	6.97674418604651	0.019287075733366	0.0757121574603186	1	1	0.968717089523898	0.971764654232744	0.642644011542639
down	PTHLH; ALOX15; LOX;	GO:0030282~bone mineralization	3	44	6.81818181818182	0.020416978201143	0.0757121574603186	1	1	0.971194626837258	0.971764654232744	0.642644011542639
up	KLF4; SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	4	8	50	0.0204182705664426	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	AQP1; SCNN1A; SCNN1B; SCNN1G;	GO:0050891~multicellular organismal water homeostasis	4	8	50	0.0204182705664426	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CES2; PTGES; HPGDS; GSTA1; HPGD; AKR1C2;	GO:0006693~prostaglandin metabolic process	6	18	33.3333333333333	0.0204477105431964	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	BCAR1; FAT1; FHOD3; SAMD14; CORO6;	GO:0007015~actin filament organization	5	121	4.13223140495868	0.0205395444052436	0.0757121574603186	1	1	0.971194626837258	0.971764654232744	0.642644011542639
down	SH3PXD2B; MMP16; CAV1; MMP17;	GO:0043085~positive regulation of catalytic activity	4	81	4.93827160493827	0.0213785495032963	0.0757121574603186	1	1	0.971764654232744	0.971764654232744	0.642644011542639
down	APP; SH3RF2; EDA2R; WNT7A;	GO:0046330~positive regulation of JNK cascade	4	81	4.93827160493827	0.0213785495032963	0.0757121574603186	1	1	0.971764654232744	0.971764654232744	0.642644011542639
up	EDN3; EDN2; EDNRB;	GO:0014826~vein smooth muscle contraction	3	4	75	0.0213961454617798	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021913~regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification	3	4	75	0.0213961454617798	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.0213961454617798	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	PLD1; TNFAIP8L3; ADAP2;	GO:0048017~inositol lipid-mediated signaling	3	4	75	0.0213961454617798	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	TJP1; ANGPT1; OCLN;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.0213961454617798	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	ASPDH; SDR42E2; KDM4E; PIR; PRODH; AKR1B10; FMO6P; ALDH1L1; BBOX1; TM7SF2; CH25H; LIPF; GSTA1; SOD3; MGST1; CYP2C9; IMPDH2; CYP4B1; HPGD; NOS3; ALDH3A1; FMO3; CYP2C19; ADH7; ALDH3B2; TDO2; AKR1C2; HCCS; HSD11B2; BDH1; CYP4A11; PRDX1; SELENBP1; DHCR24; PTGIS; ALDH1L2; CYP4A22; TXNDC8; CYB5R2; CYP4F22; IYD; DHRS11; IDO2; CYP4X1; CYP4Z2P; SDR16C5; OGFOD1; FADS6; RDH13; SDR9C7; RTN4IP1; DIO2; COX4I2; DHRS1; RDH12; DHRS9; HSD3B7; SRD5A3; MTHFD2L; L2HGDH; CYP4F11; STAB1; CYP39A1; TECR; ACAD8; CYP2J2; CYP2G1P; CYP2A6; CYP2F1; CYP2C18; PTGES;	GO:0055114~oxidation-reduction process	71	526	13.4980988593156	0.0215217180113824	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	SERPINE2; NTRK2; SHANK3;	GO:0060291~long-term synaptic potentiation	3	45	6.66666666666667	0.0215825512626819	0.0757121574603186	1	1	0.971764654232744	0.971764654232744	0.642644011542639
up	GTPBP4; WDR12; RPF2; RPL7L1; DDX18;	GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	5	13	38.4615384615385	0.0216218593978807	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	PTGES; NUPR1; S100A8; HP; HPR;	GO:0002526~acute inflammatory response	5	13	38.4615384615385	0.0216218593978807	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	ITGB4; SRPX; TBC1D5; EVA1A; TIGAR;	GO:0006914~autophagy	5	123	4.0650406504065	0.0218148685913864	0.0757121574603186	1	1	0.971764654232744	0.971764654232744	0.642644011542639
up	KLF4; IFNG; NPR3; NOS3; AIF1; PPARD; CTNNBIP1; NDRG2;	GO:0048662~negative regulation of smooth muscle cell proliferation	8	30	26.6666666666667	0.0221537436103648	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	FOXC2; SEMA3C; TBX18;	GO:0001756~somitogenesis	3	46	6.52173913043478	0.0227838085048828	0.0757121574603186	1	1	0.971764654232744	0.971764654232744	0.642644011542639
down	TGFB2; SHH; SIX1;	GO:0048839~inner ear development	3	46	6.52173913043478	0.0227838085048828	0.0757121574603186	1	1	0.971764654232744	0.971764654232744	0.642644011542639
down	PLAU; SERPINE2; ITGA2; TFPI2; SHH; EHD2;	GO:0007596~blood coagulation	6	171	3.50877192982456	0.0233803549834231	0.0757121574603186	1	1	0.971764654232744	0.971764654232744	0.642644011542639
down	CADM1; TENM2; TENM3;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	3	47	6.38297872340426	0.0240207446043657	0.0757121574603186	1	1	0.971764654232744	0.971764654232744	0.642644011542639
down	SLC4A3; KCNJ12; KCNIP3;	GO:0061337~cardiac conduction	3	47	6.38297872340426	0.0240207446043657	0.0757121574603186	1	1	0.971764654232744	0.971764654232744	0.642644011542639
up	RAMP3; ATP2C2; NFASC; ATP1B1; JUP; ATP1B3; EMP2; CAV3; RAB10; RAB11A; ANK2; DLG1; MAP7; SKAP1; DPP10; MRAP; KCNB2; NKD2; TESC; CRB3; FAM126A; EFR3B; PKP3; RAB3C;	GO:0072659~protein localization to plasma membrane	24	144	16.6666666666667	0.024072494782857	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	NTRK1; RET; AXL; EPHB4; NTRK2;	GO:0018108~peptidyl-tyrosine phosphorylation	5	127	3.93700787401575	0.0245171959554739	0.0757121574603186	1	1	0.971764654232744	0.971764654232744	0.642644011542639
down	LPXN; CLDN14; LAMC1; TEAD2; CARD10;	GO:0065003~protein-containing complex assembly	5	128	3.90625	0.0252248201094891	0.0764408357065701	1	1	0.971764654232744	0.971764654232744	0.648829024980413
down	APP; GDNF; FOXA2;	GO:0008344~adult locomotory behavior	3	48	6.25	0.0252933359527976	0.0764408357065701	1	1	0.971764654232744	0.971764654232744	0.648829024980413
down	LHX1; CNTN1; CDK5R2;	GO:0021549~cerebellum development	3	48	6.25	0.0252933359527976	0.0764408357065701	1	1	0.971764654232744	0.971764654232744	0.648829024980413
down	ITGA2; MDK; FRMD5;	GO:0045785~positive regulation of cell adhesion	3	48	6.25	0.0252933359527976	0.0764408357065701	1	1	0.971764654232744	0.971764654232744	0.648829024980413
up	HOXB1; FST; BMP5; SOSTDC1; GRHL3; SHROOM3; FOXJ1; TBX5;	GO:0007389~pattern specification process	8	31	25.8064516129032	0.0256548353698344	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	EGFR; ASS1; EIF4E; SRD5A1; AQP1; METTL21C; ERRFI1; PCK1;	GO:0071549~cellular response to dexamethasone stimulus	8	31	25.8064516129032	0.0256548353698344	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	ADH1A; CYP2A6; CYP2C9; UGT1A1; CYP2C19; TPMT; UGT1A7;	GO:0017144~drug metabolic process	7	25	28	0.0258627484422851	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CASQ2; ATP8B1; ATP10A; ATP2C2; ATP6V1G1; ATP1B1; ATP4A; CHRNA7; SCNN1A; SCNN1B; SCNN1G; ATP12A; ATP1B3; GRIK3; FXYD3; GRIK4; ATP13A4; ATP6V1C2; RYR2; TTYH1; ATP6V0A4; ASIC5; ATP6V1D; CLCA3P; CHRNA2; GLRA1; GABRD; GABRE; GABRA4; HTR3B; HTR3A; GABRB2;	GO:0034220~ion transmembrane transport	32	208	15.3846153846154	0.026202072711441	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	WNT7A; SYT1; GAD1;	GO:0007269~neurotransmitter secretion	3	49	6.12244897959184	0.0266015412672579	0.0802726211805686	1	1	0.971764654232744	0.971764654232744	0.681353180558358
down	DSCAM; APP; ETV5; RASD2;	GO:0007626~locomotory behavior	4	87	4.59770114942529	0.0266515535501974	0.0802726211805686	1	1	0.971764654232744	0.971764654232744	0.681353180558358
down	ITGA2; ITGB6; AXL; EFNB3;	GO:0046718~viral entry into host cell	4	87	4.59770114942529	0.0266515535501974	0.0802726211805686	1	1	0.971764654232744	0.971764654232744	0.681353180558358
down	APOD; ALOX15; NR2F2; HSPG2; LIPG;	GO:0006629~lipid metabolic process	5	130	3.84615384615385	0.0266790149631677	0.0802726211805686	1	1	0.971764654232744	0.971764654232744	0.681353180558358
up	ADRA2A; NOS3; CAV3; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	5	14	35.7142857142857	0.0271392537273802	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	SCNN1A; SCNN1B; SCNN1G; CYP4A11; TFAP2B;	GO:0055078~sodium ion homeostasis	5	14	35.7142857142857	0.0271392537273802	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CCR2; PLA2G4A; NLRP10; IL23A;	GO:0002827~positive regulation of T-helper 1 type immune response	4	9	44.4444444444444	0.0273522612896928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	HAAO; TDO2; IDO2; ACMSD;	GO:0006569~tryptophan catabolic process	4	9	44.4444444444444	0.0273522612896928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	PLA2G4A; CYP2J2; PTGIS; CYP4F22;	GO:0006690~icosanoid metabolic process	4	9	44.4444444444444	0.0273522612896928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	SASH1; LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	4	9	44.4444444444444	0.0273522612896928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	APOA4; LPL; CETP; APOA1;	GO:0034372~very-low-density lipoprotein particle remodeling	4	9	44.4444444444444	0.0273522612896928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	ALOX15B; FABP5; PTGIS; CITED2;	GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway	4	9	44.4444444444444	0.0273522612896928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	WNT7A; PRICKLE2; SMURF2; GPC6;	GO:0060071~Wnt signaling pathway, planar cell polarity pathway	4	88	4.54545454545455	0.0275992909702216	0.0820454385875945	1	1	0.971764654232744	0.971764654232744	0.696400836422356
down	ELFN1; ELFN2; SH3RF2;	GO:0010923~negative regulation of phosphatase activity	3	50	6	0.0279453021872764	0.0829835444036117	1	1	0.971764654232744	0.971764654232744	0.704363468912029
down	TBX3; LIF; NODAL;	GO:0019827~stem cell population maintenance	3	51	5.88235294117647	0.0293245438578186	0.0865137516844301	1	1	0.971764654232744	0.971764654232744	0.734327831897078
down	CSF3; ALOX15; CCL26;	GO:0030838~positive regulation of actin filament polymerization	3	51	5.88235294117647	0.0293245438578186	0.0865137516844301	1	1	0.971764654232744	0.971764654232744	0.734327831897078
down	ELFN1; ELFN2; SH3RF2;	GO:0032515~negative regulation of phosphoprotein phosphatase activity	3	51	5.88235294117647	0.0293245438578186	0.0865137516844301	1	1	0.971764654232744	0.971764654232744	0.734327831897078
down	SLC26A4; SIX1; SIX4;	GO:0032880~regulation of protein localization	3	51	5.88235294117647	0.0293245438578186	0.0865137516844301	1	1	0.971764654232744	0.971764654232744	0.734327831897078
down	TBX1; GAD1; SHANK3;	GO:0035176~social behavior	3	51	5.88235294117647	0.0293245438578186	0.0865137516844301	1	1	0.971764654232744	0.971764654232744	0.734327831897078
down	WTIP; HOXC6; CDYL2;	GO:1903507~negative regulation of nucleic acid-templated transcription	3	51	5.88235294117647	0.0293245438578186	0.0865137516844301	1	1	0.971764654232744	0.971764654232744	0.734327831897078
down	SCG5; NOTCH1; SNCB;	GO:0043086~negative regulation of catalytic activity	3	52	5.76923076923077	0.0307391754980523	0.0901991306864268	1	1	0.971764654232744	0.971764654232744	0.765609290850872
down	SH3PXD2B; SNAI2; SFRP1;	GO:0045600~positive regulation of fat cell differentiation	3	52	5.76923076923077	0.0307391754980523	0.0901991306864268	1	1	0.971764654232744	0.971764654232744	0.765609290850872
down	TNFRSF10B; PRKD1; AJUBA; LURAP1; NEK6; EDA2R;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	6	183	3.27868852459016	0.0308691487363333	0.0903151141400254	1	1	0.971764654232744	0.971764654232744	0.766593757208633
up	LTF; RARRES2; IL36RN;	GO:0019732~antifungal humoral response	3	5	60	0.0318849363292928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	ATP8B1; PLD1; KLF5;	GO:0032534~regulation of microvillus assembly	3	5	60	0.0318849363292928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0318849363292928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	IL10; IL18; BCL6B;	GO:0042092~type 2 immune response	3	5	60	0.0318849363292928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	EGFR; DUOXA1; DUOXA2;	GO:0042743~hydrogen peroxide metabolic process	3	5	60	0.0318849363292928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	HPGD; FOXF1; TFAP2B;	GO:0097070~ductus arteriosus closure	3	5	60	0.0318849363292928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	HSPA2; RGN; RYR2;	GO:1901896~positive regulation of ATPase-coupled calcium transmembrane transporter activity	3	5	60	0.0318849363292928	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	CAV1; BVES; TIGAR;	GO:0002931~response to ischemia	3	53	5.66037735849057	0.0321890909572766	0.0903151141400254	1	1	0.971764654232744	0.971764654232744	0.766593757208633
up	MPZL2; CDH16; CEACAM5; DSG3; CEACAM6; DSG1; DSC2; PCDH1; DSC3; IGSF11; CADM3; CLSTN2; ROBO2; CD84; CDH22; PCDHGB4; PCDHA4; IGSF9B; PCDHB5; PCDHGC4; NECTIN4; CNTN4; CDH19; ROBO4; IGSF21; CDH12;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	26	165	15.7575757575758	0.0334096555396425	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	PGR; TACSTD2; EDNRB; SERPINB5; HES5;	GO:0050678~regulation of epithelial cell proliferation	5	15	33.3333333333333	0.0334752522139007	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	KLF4; ID1; CASR; KLF5; KLF15;	GO:1901653~cellular response to peptide	5	15	33.3333333333333	0.0334752522139007	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	ETV5; DHRS2; PRKD1; GPX8;	GO:0034599~cellular response to oxidative stress	4	94	4.25531914893617	0.0337049927396892	0.0903151141400254	1	1	0.971764654232744	0.971764654232744	0.766593757208633
up	IL18RAP; IGF1; GLUL; PAX1; LTK; EMP2; DLX5; PPARD; PRDX1; FOXC1; IL18; FAM83B; GRHL2; OGFOD1; ALKBH3; CITED2; GNL3; SDCBP2; FAM83D; PAK1IP1; PAK5; ZPR1; TACC2;	GO:0008283~cell population proliferation	23	142	16.1971830985916	0.0343217318064561	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	FBXL7; FBXO2; FBXL2; LRRC29;	GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	4	95	4.21052631578947	0.0347929105137403	0.0903151141400254	1	1	0.971764654232744	0.971764654232744	0.766593757208633
up	APOA1; APOC3; LPL; CETP; IL18; GPIHBP1; APOA4;	GO:0070328~triglyceride homeostasis	7	27	25.9259259259259	0.0351274244446378	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	ADAMTS3; MMP14; MMP16;	GO:0016485~protein processing	3	55	5.45454545454545	0.0351942751217378	0.0903151141400254	1	1	0.971764654232744	0.971764654232744	0.766593757208633
down	TGFB1I1; ONECUT2; WNT7A;	GO:0045165~cell fate commitment	3	55	5.45454545454545	0.0351942751217378	0.0903151141400254	1	1	0.971764654232744	0.971764654232744	0.766593757208633
up	GCAT; ALDH1L1; ALDH1L2; KYAT3;	GO:0009058~biosynthetic process	4	10	40	0.0355245209480415	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	KLF4; APOA1; IL1RN; IL10;	GO:0034115~negative regulation of heterotypic cell-cell adhesion	4	10	40	0.0355245209480415	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	APOA1; APOC3; APOB; APOA4;	GO:0034378~chylomicron assembly	4	10	40	0.0355245209480415	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	DLG1; SGCD; SEH1L; MIOS;	GO:0034629~cellular protein-containing complex localization	4	10	40	0.0355245209480415	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	4	10	40	0.0355245209480415	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	PSCA; PATE4; SLURP1; LYPD6B;	GO:0099601~regulation of neurotransmitter receptor activity	4	10	40	0.0355245209480415	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	SIPA1L3; FGD1; SYDE1; ARHGAP22; DLC1;	GO:0051056~regulation of small GTPase mediated signal transduction	5	141	3.54609929078014	0.0356255315519352	0.0903151141400254	1	1	0.971764654232744	0.971764654232744	0.766593757208633
down	PCBP4; SOX4; E2F7;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	3	56	5.35714285714286	0.0367492594946198	0.0903322645467391	1	1	0.971764654232744	0.971764654232744	0.76673932968391
down	PTK7; SYDE1; ANTXR1;	GO:0031532~actin cytoskeleton reorganization	3	56	5.35714285714286	0.0367492594946198	0.0903322645467391	1	1	0.971764654232744	0.971764654232744	0.76673932968391
down	BMPR1B; RET; RP1;	GO:0060041~retina development in camera-type eye	3	56	5.35714285714286	0.0367492594946198	0.0903322645467391	1	1	0.971764654232744	0.971764654232744	0.76673932968391
up	IGLV1-50; TRBV19; TRBV20-1; TRGV2; IGLV5-52; TRAV19; TRAV13-1; IGKV3D-7; TRBV27; TRBV7-2; TRBV28; LILRA1; JCHAIN; HLA-DQA2; TRGV3; TRGC2; ANXA1; CD3D; TRBV7-9; HLA-DQB2; CD1A; CD3G; TRGC1; CD8B; CD1E; CTLA4; HLA-DMB; CD1B; CD1C; CD79B; ARG2; SLAMF1; TRAT1; NLRP10; SKAP1; CLEC10A; ZNF683; LILRB2; LILRB1; FCAMR; FCGR1B; SIGLEC10; CD209; CD84; LAMP3; SIT1; IFNG; TEC;	GO:0002250~adaptive immune response	48	347	13.8328530259366	0.0368574932803425	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	IGF1R; MFAP2; CAV1; DYNC1H1;	GO:0120162~positive regulation of cold-induced thermogenesis	4	97	4.12371134020619	0.0370292899559647	0.0909385985765402	1	1	0.971764654232744	0.971764654232744	0.77188588667445
down	TNFRSF10B; FN1; CD44; ITGA3; L1CAM; CAV1;	GO:0050900~leukocyte migration	6	193	3.10880829015544	0.0381876763941943	0.0932792167119835	1	1	0.971764654232744	0.971764654232744	0.791753029264318
down	THBS1; ITGA2; CDH13;	GO:0048661~positive regulation of smooth muscle cell proliferation	3	57	5.26315789473684	0.0383389600435319	0.0935649105449131	1	1	0.971764654232744	0.971764654232744	0.794177995571256
up	PRKAR2A; AQP1; AVPR2; RAB11A; CYP4A11; ADCY2; TFAP2B; MYO5B;	GO:0003091~renal water homeostasis	8	34	23.5294117647059	0.0384224121793652	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	PTPRG; PTPRK; PTPN14; PTPRU;	GO:0035335~peptidyl-tyrosine dephosphorylation	4	99	4.04040404040404	0.0393465108723561	0.0959379147030793	1	1	0.971764654232744	0.971764654232744	0.814320030387931
up	ATP6V1G1; RAB38; RAB39A; ATP6V1C2; ATP6V0A4; SLAMF8; ATP6V1D;	GO:0090383~phagosome acidification	7	28	25	0.0404885926591843	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	MT1X; MT1A; MT1H; MT1M; MT1G;	GO:0010273~detoxification of copper ion	5	16	31.25	0.0406555607687984	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CSTA; CSTB; SERPINB3; SERPINB4; ECM1;	GO:0010466~negative regulation of peptidase activity	5	16	31.25	0.0406555607687984	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	ADRA2A; EDN3; EDN2; BDKRB2; ACE2;	GO:0019229~regulation of vasoconstriction	5	16	31.25	0.0406555607687984	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	EDN3; EDN2; KEL; EDNRB; BDKRB2;	GO:0042310~vasoconstriction	5	16	31.25	0.0406555607687984	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	SOX4; PRKD1; TEAD2;	GO:0060548~negative regulation of cell death	3	59	5.08474576271187	0.0416217969052886	0.100764669950104	1	1	0.971764654232744	0.971764654232744	0.855289479136078
down	APP; MMP14; CYGB; PXDN;	GO:0006979~response to oxidative stress	4	102	3.92156862745098	0.0429740482260313	0.102848206388959	1	1	0.971764654232744	0.971764654232744	0.872974514937139
down	ISL1; TGFB2; SFRP1;	GO:0050680~negative regulation of epithelial cell proliferation	3	60	5	0.0433145465490435	0.102848206388959	1	1	0.971764654232744	0.971764654232744	0.872974514937139
up	EREG; EGFR; PTPN3; BTC; EPGN; TSG101; CBLC; ERRFI1;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	8	35	22.8571428571429	0.0434789539541423	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	WNT7A; NR2F2; MAP1B; POSTN;	GO:0032355~response to estradiol	4	103	3.88349514563107	0.0442236719655844	0.102848206388959	1	1	0.971764654232744	0.971764654232744	0.872974514937139
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.0445636703847949	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	DSP; GRHL1; PERP;	GO:0002934~desmosome organization	3	6	50	0.0445636703847949	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	EDN3; EDN2; NOS3;	GO:0003100~regulation of systemic arterial blood pressure by endothelin	3	6	50	0.0445636703847949	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CXCL13; CH25H; HSD3B7;	GO:0035754~B cell chemotaxis	3	6	50	0.0445636703847949	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	FOXF1; CD300A; CD84;	GO:0043305~negative regulation of mast cell degranulation	3	6	50	0.0445636703847949	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	ANXA1; CD80; CCL19;	GO:0045627~positive regulation of T-helper 1 cell differentiation	3	6	50	0.0445636703847949	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.0445636703847949	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	ATP1B1; ATP1B3; ANK2;	GO:1901018~positive regulation of potassium ion transmembrane transporter activity	3	6	50	0.0445636703847949	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	IFNG; CCL2; CCR2;	GO:1904783~positive regulation of NMDA glutamate receptor activity	3	6	50	0.0445636703847949	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.0445636703847949	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	FUT3; FUT2; FUT7; FUT6;	GO:0036065~fucosylation	4	11	36.3636363636364	0.0449541017601846	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	EFNB1; CD276; PDCD1LG2;	GO:0042102~positive regulation of T cell proliferation	3	61	4.91803278688525	0.0450412399575568	0.102848206388959	1	1	0.971764654232744	0.971764654232744	0.872974514937139
down	GRK5; ADRA1D; ADRA1B;	GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway	3	62	4.83870967741935	0.0468016555756523	0.102848206388959	1	1	0.971764654232744	0.971764654232744	0.872974514937139
down	WNT7A; MMP14; CAV1;	GO:0043627~response to estrogen	3	62	4.83870967741935	0.0468016555756523	0.102848206388959	1	1	0.971764654232744	0.971764654232744	0.872974514937139
down	NTRK1; APP; CAV1; PRKD1; EDA2R;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	5	154	3.24675324675325	0.0483290003516521	0.102848206388959	1	1	0.971764654232744	0.971764654232744	0.872974514937139
up	IL2RA; IGF1; IGFBP2; CD24; IL18; IL23A;	GO:0042104~positive regulation of activated T cell proliferation	6	23	26.0869565217391	0.0484306025769342	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
down	AGRN; HSPG2; GPC6;	GO:0001523~retinoid metabolic process	3	63	4.76190476190476	0.0485955613547022	0.102850543674626	1	1	0.971764654232744	0.971764654232744	0.872994353793771
up	CCL21; TRPM2; CCR2; CCR5; CCL19;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.0486969454972681	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	CCL21; AIF1; CCL19; RARRES2; P2RY12;	GO:0050921~positive regulation of chemotaxis	5	17	29.4117647058824	0.0486969454972681	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
up	GRM6; ATP2C2; CCL2; LGALS3; CASR;	GO:0090280~positive regulation of calcium ion import	5	17	29.4117647058824	0.0486969454972681	0.756508855859843	1	1	0.999999999716638	0.999999999716637	1
